v3.25.1
Cover
6 Months Ended
Mar. 31, 2025
shares
Cover [Abstract]  
Document Type 10-Q
Document Quarterly Report true
Document Period End Date Mar. 31, 2025
Document Transition Report false
Entity File Number 001-37757
Entity Registrant Name Adient plc
Entity Incorporation, State or Country Code L2
Entity Tax Identification Number 98-1328821
Entity Address, Address Line One 3 Dublin Landings
Entity Address, Address Line Two North Wall Quay
Entity Address, City or Town Dublin 1
Entity Address, Country IE
Entity Address, Postal Zip Code D01 H104
City Area Code 734
Local Phone Number 254-5000
Title of 12(b) Security Ordinary Shares, par value $0.001
Trading Symbol ADNT
Security Exchange Name NYSE
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Large Accelerated Filer
Entity Small Business false
Entity Emerging Growth Company false
Entity Shell Company false
Entity Common Stock, Shares Outstanding 84,016,644
Entity Central Index Key 0001670541
Current Fiscal Year End Date --09-30
Document Fiscal Year Focus 2025
Document Fiscal Period Focus Q2
Amendment Flag false
v3.25.1
Consolidated Statements of Income (Loss) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]        
Net sales $ 3,611 $ 3,750 $ 7,106 $ 7,410
Cost of sales 3,350 3,520 6,629 6,934
Gross profit 261 230 477 476
Selling, general and administrative expenses 144 115 269 262
Restructuring and impairment costs 351 125 374 136
Equity income 18 18 43 41
Earnings before interest and income taxes (216) 8 (123) 119
Net financing charges 48 47 93 91
Other pension expense 1 2 2 4
Income (loss) before income taxes (265) (41) (218) 24
Income tax provision 48 8 70 28
Net loss (313) (49) (288) (4)
Income attributable to noncontrolling interests 22 21 47 46
Net loss attributable to Adient $ (335) $ (70) $ (335) $ (50)
Loss per share:        
Basic (in usd per share) $ (3.99) $ (0.77) $ (3.98) $ (0.55)
Diluted (in usd per share) $ (3.99) $ (0.77) $ (3.98) $ (0.55)
Shares used in computing earnings per share:        
Basic (in shares) 84.0 90.5 84.2 91.7
Diluted (in shares) 84.0 90.5 84.2 91.7
v3.25.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Statement of Comprehensive Income [Abstract]        
Net loss $ (313) $ (49) $ (288) $ (4)
Other comprehensive income, net of tax:        
Foreign currency translation adjustments 94 (102) (142) 40
Realized and unrealized gains (losses) on derivatives 17 (6) 9 3
Other comprehensive income (loss) 111 (108) (133) 43
Total comprehensive income (loss) (202) (157) (421) 39
Comprehensive income attributable to noncontrolling interests 27 11 33 49
Comprehensive loss attributable to Adient $ (229) $ (168) $ (454) $ (10)
v3.25.1
Consolidated Statements of Financial Position - USD ($)
$ in Millions
Mar. 31, 2025
Sep. 30, 2024
Assets    
Cash and cash equivalents $ 754 $ 945
Accounts receivable - net 1,887 1,896
Inventories 719 758
Other current assets 532 487
Current assets 3,892 4,086
Property, plant and equipment - net 1,344 1,410
Goodwill 1,784 2,164
Other intangible assets - net 336 371
Investments in partially-owned affiliates 293 338
Assets held for sale 7 8
Other noncurrent assets 933 974
Total assets 8,589 9,351
Liabilities and Shareholders' Equity    
Short-term debt 2 1
Current portion of long-term debt 8 8
Accounts payable 2,472 2,552
Accrued compensation and benefits 327 358
Other current liabilities 700 759
Current liabilities 3,509 3,678
Long-term debt 2,386 2,396
Pension and postretirement benefits 97 105
Other noncurrent liabilities 577 638
Long-term liabilities 3,060 3,139
Commitments and Contingencies (Note 17)
Redeemable noncontrolling interests 71 91
Preferred shares issued, par value $0.001; 100,000,000 shares authorized, Zero shares issued and outstanding at March 31, 2025 0 0
Ordinary shares issued, par value $0.001; 500,000,000 shares authorized, 84,016,644 shares issued and outstanding at March 31, 2025 0 0
Additional paid-in capital 3,686 3,712
Accumulated deficit (1,220) (885)
Accumulated other comprehensive loss (814) (693)
Shareholders' equity attributable to Adient 1,652 2,134
Noncontrolling interests 297 309
Total shareholders' equity 1,949 2,443
Total liabilities and shareholders' equity $ 8,589 $ 9,351
v3.25.1
Consolidated Statements of Financial Position (Parenthetical)
Mar. 31, 2025
$ / shares
shares
Statement of Financial Position [Abstract]  
Preferred stock, par value (in usd per share) | $ / shares $ 0.001
Preferred stock, shares authorized (in shares) 100,000,000
Preferred stock, shares issued (in shares) 0
Preferred stock, shares outstanding (in shares) 0
Common stock, par value (in usd per share) | $ / shares $ 0.001
Common stock, shares authorized (in shares) 500,000,000
Common stock, shares issued (in shares) 84,016,644
Common stock, shares outstanding (in shares) 84,016,644
v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating Activities    
Net loss attributable to Adient $ (335) $ (50)
Income attributable to noncontrolling interests 47 46
Net loss (288) (4)
Adjustments to reconcile net income to cash provided (used) by operating activities:    
Depreciation 136 142
Amortization of intangibles 23 23
Pension and postretirement expense 5 6
Pension and postretirement contributions, net (13) (16)
Equity in earnings of partially-owned affiliates, net of dividends received 14 (20)
Gain on sale of interests in nonconsolidated partially-owned affiliates (4) 0
Deferred income taxes 17 (7)
Non-cash impairment charges 343 0
Equity-based compensation 10 23
Other 2 2
Changes in assets and liabilities excluding impact of acquisitions/divestitures:    
Receivables (37) (33)
Inventories 24 56
Other assets (75) (59)
Accounts payable and accrued liabilities (106) 27
Accrued income taxes 13 (18)
Cash provided by operating activities 64 122
Investing Activities    
Capital expenditures (109) (124)
Sale of property, plant and equipment 8 14
Business divestitures 27 (3)
Other (4) 0
Cash used by investing activities (78) (113)
Financing Activities    
Increase (decrease) in short-term debt 1 (2)
Increase in long-term debt 795 0
Repayment of long-term debt (799) (1)
Debt financing costs (13) (5)
Share repurchases (25) (150)
Acquisition of a noncontrolling interest (28) 0
Dividends paid to and other transactions with noncontrolling interests (77) (51)
Share based compensation and other (3) (12)
Cash used by financing activities (149) (221)
Effect of exchange rate changes on cash and cash equivalents (28) 7
Decrease in cash and cash equivalents (191) (205)
Cash and cash equivalents at beginning of period 945 1,110
Cash and cash equivalents at end of period $ 754 $ 905
v3.25.1
Organization and Summary of Significant Accounting Policies
6 Months Ended
Mar. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Summary of Significant Accounting Policies
1. Organization and Summary of Significant Accounting Policies

Adient is a global leader in the automotive seating supplier industry and maintains relationships with the largest global automotive original equipment manufacturers, or OEMs. Adient's proprietary technologies extend into virtually every area of automotive seating solutions, including complete seating systems, frames, mechanisms, foam, head restraints, armrests and trim covers. Adient is an independent seat supplier with global scale and the capability to design, develop, engineer, manufacture, and deliver complete seat systems and components in every major automotive producing region in the world.

Basis of Presentation
The unaudited consolidated financial statements of Adient have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission and in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). These interim consolidated financial statements include all adjustments (consisting of normal recurring adjustments) that management believes are necessary for a fair statement of the results of operations, financial position and cash flows of Adient for the interim periods presented. Certain figures for comparative periods were regrouped to conform to current period presentation.

Principles of Consolidation
Adient consolidates its wholly-owned subsidiaries and those entities in which it has a controlling interest. Investments in partially-owned affiliates are accounted for by the equity method when Adient's interest exceeds 20% and does not have a controlling interest.
Consolidated VIEs
Based upon the criteria set forth in the Financial Accounting Standards Board (the "FASB") Accounting Standards Codification ("ASC") 810, "Consolidation," Adient has determined that it was the primary beneficiary in two variable interest entities ("VIEs") for the reporting periods ended March 31, 2025, and September 30, 2024, as Adient absorbs significant economics of the entities and has the power to direct the activities that are considered most significant to the entities.
The two VIEs manufacture seating products in North America for the automotive industry. Adient funds the entities' short-term liquidity needs through revolving credit facilities and has the power to direct the activities that are considered most significant to the entities through its key customer supply relationships.
The carrying amounts and classification of assets (none of which is restricted) and liabilities included in Adient's consolidated statements of financial position for the consolidated VIEs are as follows:

(in millions)March 31, 2025September 30, 2024
Current assets$309 $285 
Noncurrent assets95 98 
Total assets$404 $383 
Current liabilities$267 $241 
Noncurrent liabilities11 12 
Total liabilities$278 $253 
Earnings Per Share
The following table reconciles the numerators and denominators used to calculate basic and diluted loss per share:
Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions, except per share data)2025202420252024
Income available to shareholders
Net loss attributable to Adient$(335)$(70)$(335)$(50)
Weighted average shares outstanding
Basic weighted average shares outstanding84.0 90.5 84.2 91.7 
Effect of dilutive securities:
Stock options, unvested restricted stock and unvested performance share awards— — — — 
Diluted weight average shares outstanding84.0 90.5 84.2 91.7 
Loss per share:
Basic$(3.99)$(0.77)$(3.98)$(0.55)
Diluted$(3.99)$(0.77)$(3.98)$(0.55)
Potentially dilutive securities whose effect would have been anti-dilutive are excluded from the computation of diluted earnings per share for the three and six months ended March 31, 2025 and 2024 as a result of being in a loss position.

New Accounting Pronouncements

Standards to be Adopted During Fiscal 2025

Adient will adopt Accounting Standards Codification ("ASU") 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures in fiscal 2025 which requires additional disclosures on significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss (collectively referred to as the “significant expense principle”). The ASU also requires additional disclosures of an amount for other segment items by reportable segment and a description of its composition. The new guidance will be applied retrospectively in Adient's fiscal 2025 annual filing on Form 10-K and in subsequent quarterly filings on Form 10-Q. The adoption of this guidance is expected to result in incremental segment information disclosures within the footnotes to the consolidated financial statements.

Standards Effective After Fiscal 2025

Adient has considered the new standards that are summarized below, each to be effective after fiscal 2025:

Standard to be AdoptedDescriptionDate Effective
ASU 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures.The ASU requires disclosure of additional details about the reporting entity's reconciliation of the effective tax rate to the statutory rate for federal, state, and foreign income taxes. The ASU also requires further disaggregation of income tax amounts paid by federal, state and foreign, as well as by material jurisdiction.October 1, 2025
ASU 2024-03 Income Statement - Reporting Comprehensive
Income - Expense: Disaggregation Disclosures
(Subtopic 220-40)
The ASU requires disclosures of specified information about certain costs and expenses in the notes to financial statements at each interim and annual reporting period, including: the amounts of purchases of inventory, employee compensation, depreciation, intangible asset amortization, and a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. It also requires disclosures of the total amount of selling expenses and, in annual reporting periods, an entity’s definition of selling expenses.October 1, 2027
v3.25.1
Revenue Recognition
6 Months Ended
Mar. 31, 2025
Revenue from Contract with Customer [Abstract]  
Revenue Recognition
2. Revenue Recognition

Adient generates revenue through the sale of automotive seating solutions, including complete seating systems and the components of complete seating systems. Adient provides production and service parts to its customers under awarded multi-year programs. The duration of a program is generally consistent with the life cycle of a vehicle; however, the program can be canceled at any time without cause by the customer. Programs awarded to Adient to supply parts to its customers do not contain a firm commitment by the customer for volume or price and do not reach the level of a performance obligation until Adient receives either a purchase order and/or a materials release from the customer for a specific number of parts at a specified price, at which point an enforceable contract exists. Sales revenue is generally recognized at the point in time when parts are shipped and control has transferred to the customer, at which point an enforceable right to payment exists. Contracts may provide for annual price reductions over the production life of the awarded program, and prices are adjusted on an ongoing basis to reflect changes in product content/cost and other commercial factors. The amount of revenue recognized reflects the consideration that Adient expects to be entitled to in exchange for such products based on purchase orders, annual price reductions and ongoing price adjustments (some of which are accounted for as variable consideration and subject to being constrained), net of the impact, if any, of consideration paid to the customer. Approximately 2% of net sales recorded during the second quarter of fiscal 2025 were related to product sales transacted in prior periods.

In pursuit of new program awards, Adient at times agrees to make upfront payments to customers. Each time such a payment is made, Adient evaluates its nature, the underlying economics, legal and compliance ramifications, and other relevant factors and circumstances. These payments are deemed to be consideration payable to customers and are generally recognized as a reduction to revenue once mutually agreed. Certain upfront payments, however, are capitalized as other current and noncurrent assets if they are determined to be incremental, attributable only to the specific new program being awarded, and recoverable. As products under the new program are sold to the customer, the capitalized amount is amortized and recognized as a reduction to revenue over the term of the program, typically between three and seven years. Adient assesses recoverability of the capitalized amounts on an on-going basis. Any amounts that are concluded to be no longer recoverable are immediately recognized as a reduction to revenue. As of March 31, 2025 and September 30, 2024, Adient maintained capitalized upfront payments of $160 million and $155 million, respectively, within other noncurrent assets.

In a typical arrangement with the customer, purchase orders are issued for pre-production activities which consist of engineering, design and development, tooling and prototypes for the manufacture and delivery of component parts. Adient has concluded that these activities are not in the scope of ASC 606, "Revenue from Contracts with Customers."

Adient includes shipping and handling fees billed to customers in revenue, while including costs of shipping and handling in cost of sales. Taxes collected from customers are excluded from revenue and credited directly to obligations to the appropriate government agencies. Payment terms with customers are established based on customary industry and regional practices and do not contain significant financing components.

Contract assets primarily relate to the right to consideration for work completed, but not billed at the reporting date on contracts with customers. The contract assets are transferred to receivables when the rights become unconditional. Contract liabilities primarily relate to contracts where advance payments or deposits have been received, but performance obligations have not yet been satisfied and revenue has not been recognized. No significant contract assets or liabilities exist at March 31, 2025 or at September 30, 2024. As described above, the issuance of a purchase order and/or a materials release by the customer represents the point at which an enforceable contract with the customer exists. Therefore, Adient has elected to apply the practical expedient in ASC 606, paragraph 606-10-50-14 and does not disclose information about the remaining performance obligations that have an original expected duration of one year or less. Refer to Note 15, "Segment Information," of the notes to the consolidated financial statements for disaggregated revenue by geographical market.
v3.25.1
Acquisitions and Divestitures
6 Months Ended
Mar. 31, 2025
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Acquisitions and Divestitures
3. Acquisitions and Divestitures

During the first quarter of fiscal 2025, Adient acquired all of the noncontrolling interest in Technotrim, Inc. ("Technotrim") for a value of $28 million and sold all of its partially-owned interests in Setex, Inc. and Setex SRL (together as "Setex") for a value of $27 million. The sale of Setex resulted in a one-time gain on sale of $4 million. The acquisition of all noncontrolling interest
in Technotrim was recorded to equity. The transactions are expected to provide additional synergies through optimization of Adient's manufacturing footprint and having more control over its manufacturing presence in the Americas.
During the first quarter of fiscal 2024, Adient finalized the sale of 51% of its interest (previously held 100%) in Adient (Langfang) Seating Co., Ltd. ("LFADNT") in China for ¥44 million ($6 million), resulting in the deconsolidation of LFADNT, including $9 million of cash. Adient recorded an $8 million loss as a result of the transaction in the Asia segment, including $5 million of allocated goodwill.
v3.25.1
Inventories
6 Months Ended
Mar. 31, 2025
Inventory Disclosure [Abstract]  
Inventories
4. Inventories

Inventories consisted of the following:

(in millions)March 31, 2025September 30, 2024
Raw materials and supplies$550 $582 
Work-in-process29 29 
Finished goods140 147 
Inventories$719 $758 
v3.25.1
Goodwill and Other Intangible Assets
6 Months Ended
Mar. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets
5. Goodwill and Other Intangible Assets

The changes in the carrying amount of goodwill are as follows:

(in millions)AmericasEMEAAsiaTotal
Balance at September 30, 2024$606 $341 $1,217 $2,164 
Impairment— (333)— (333)
Currency translation(2)(8)(37)(47)
Balance at March 31, 2025
$604 $— $1,180 $1,784 

Adient identified a triggering event requiring a quantitative impairment analysis as of March 31, 2025 primarily due to the continued and sustained decline in the market value of its ordinary shares during the second quarter of fiscal 2025 resulting from the uncertainties surrounding future production volume within the automotive industry. These uncertainties are the result of a combination of factors including weakening consumer demand due in part to vehicle affordability, the direct and indirect impacts resulting from the imposition of U.S. and foreign tariffs, market share loss for foreign/luxury OEMs in the Asia reporting unit combined with modest expected margin declines as Adient continues to win new business with local OEMs in China, intensifying competition from Chinese imports and lower exports to China from EMEA as domestic brands expand in China, overcapacity in the EMEA reporting unit resulting in pricing pressure along with continued disruptions caused by slower electric vehicle adoption rates. The analysis was performed using a fair value method based on management's judgments and assumptions regarding future cash flows for all three reporting units. These calculations contain uncertainties as they require management to make assumptions about market comparables, future cash flows, and the appropriate discount rates (based on weighted average cost of capital ranging from 16.5% to 21.0%) to reflect the risk inherent in the future cash flows and to derive a reasonable enterprise value and related premium. The estimated future cash flows reflect management's latest assumptions of the financial projections based on current and anticipated competitive landscape, including estimates of revenue based on production volumes over the foreseeable future and long-term growth rates, and operating margins based on historical trends and future cost containment activities. The financial projections considered the impact of all of the factors identified above, which contributed to a reduction in reporting unit level and overall fair value. As a result of the quantitative assessment and for the factors stated above, a $333 million non-cash goodwill impairment was recorded in the EMEA reporting unit during the quarter ended March 31, 2025. This amount is reflected in restructuring and impairment costs within the consolidated statements of income (loss). No amounts of goodwill remain recorded as of March 31, 2025 in EMEA. The Americas and Asia reporting units also showed significant declines in fair value, however, the differences between their fair values and carrying values both modestly exceeded 10% at March 31, 2025. The decrease in Americas' fair value is primarily attributable to the direct and indirect impacts stemming from the imposition of U.S. and foreign tariffs, and the decrease in Asia's fair value is
primarily attributable to the market share loss for foreign/luxury OEMs in the region combined with modest expected margin declines as Adient continues to win new business with local OEMs in China. Management will continue to monitor economic conditions and will test for impairment either annually or upon the identification of another triggering event.

If further degradation in economic conditions occur, Adient’s reporting units may incur significant impairment of goodwill and other long-lived assets. Adient generally assumes operating margins in future years will normalize over time as the current year results are not indicative of market participant expectations primarily due to the current challenging market conditions as mentioned above. Management believes this is consistent with a market participant view. There are also expectations for enhanced profitability and cash flows driven by near-term efficiency actions, strategic review of portfolio and reduction of capital expenditures. Long-term profitability and cash flows will also be impacted by the expiration of underperforming contracts along with restructuring benefits taking full effect.

Refer to Note 15, "Segment Information," of the notes to the consolidated financial statements for more information on Adient's reportable segments.

Adient's intangible assets, primarily from business acquisitions valued based on independent appraisals, consisted of:

 March 31, 2025September 30, 2024
(in millions)Gross
Carrying
Amount
Accumulated
Amortization
NetGross
Carrying
Amount
Accumulated
Amortization
Net
Intangible assets
Patented technology$79 $(41)$38 $81 $(39)$42 
Customer relationships531 (244)287 563 (246)317 
Trademarks and other14 (3)11 25 (13)12 
Total intangible assets$624 $(288)$336 $669 $(298)$371 

Amortization of intangible assets for the six months ended March 31, 2025 and 2024 was $23 million for each period.
v3.25.1
Product Warranties
6 Months Ended
Mar. 31, 2025
Product Warranties Disclosures [Abstract]  
Product Warranties
6. Product Warranties

Adient offers warranties to its customers depending upon the specific product and terms of the customer purchase agreement. A typical warranty program requires that Adient replace defective products within a specified time period from the date of sale. Adient records an estimate for future warranty-related costs based on actual historical return rates and other known factors. Based on analysis of return rates and other factors, Adient's warranty provisions are adjusted as necessary. Adient monitors its warranty activity and adjusts its reserve estimates when it is probable that future warranty costs will be different than those estimates. Adient's product warranty liability is recorded in the consolidated statements of financial position in other current liabilities.
The changes in Adient's total product warranty liability are as follows:
Six Months Ended
March 31,
(in millions)20252024
Balance at beginning of period$22 $21 
Accruals for warranties issued during the period
Settlements/adjustments made (in cash or in kind) during the period(5)(4)
Balance at end of period$20 $21 
v3.25.1
Leases
6 Months Ended
Mar. 31, 2025
Leases [Abstract]  
Leases
7. Leases

Adient's lease portfolio consists of operating leases for real estate including production facilities, warehouses and administrative offices, equipment such as forklifts and computer servers and laptops, and fleet vehicles.

The components of lease costs included in the consolidated statements of income (loss) for the three and six months ended March 31, 2025 and 2024 were as follows:

Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)2025202420252024
Operating lease cost$27 $27 $54 $54 
Short-term lease cost14 15 
Total lease cost$34 $35 $68 $69 

Operating lease right-of-use assets and lease liabilities included in the consolidated statements of financial position were as follows:

(in millions)March 31, 2025September 30, 2024
Operating leases:
Operating lease right-of-use assetsOther noncurrent assets$240$248
Operating lease liabilities - currentOther current liabilities$80$78
Operating lease liabilities - noncurrentOther noncurrent liabilities158168
$238$246
Weighted average remaining lease term:
Operating leases5 years5 years
Weighted average discount rate:
Operating leases6.1 %6.2 %

Maturities of operating lease liabilities and minimum payments for operating leases having initial or remaining non-cancelable terms in excess of one year as of March 31, 2025 are as follows:

Operating leases
Fiscal years (in millions)March 31, 2025
2025 (excluding the six months ended March 31, 2025)
$49 
202675 
202754 
202834 
202918 
Thereafter43 
Total lease payments273 
Less: imputed interest(35)
Present value of lease liabilities$238 
Supplemental cash flow information related to leases is as follows:

Six Months Ended
March 31,
(in millions)20252024
Right-of-use assets obtained in exchange for lease obligations:
Operating leases (non-cash activity)$40 $51 
Operating cash flows:
Cash paid for amounts included in the measurement of lease liabilities$53 $55 
v3.25.1
Debt and Financing Arrangements
6 Months Ended
Mar. 31, 2025
Debt Disclosure [Abstract]  
Debt and Financing Arrangements
8. Debt and Financing Arrangements
Long-term and short-term debt consisted of the following:

(in millions)March 31, 2025September 30, 2024
Long-term debt:
8.25% Notes due 2031
$500 $500 
7.00% Secured Notes due 2028
500 500 
Term Loan B due in 2031629 632 
4.875% Notes due in 2026
— 795 
7.50% Notes due in 2033
795 — 
Other bank borrowings and finance lease obligations
Less: debt issuance costs(35)(28)
Gross long-term debt2,394 2,404 
Less: current portion
Net long-term debt$2,386 $2,396 
Short-term debt:
Other bank borrowings$$
Total short-term debt$$

Adient US LLC ("Adient US"), a wholly owned subsidiary of Adient, together with certain of Adient's other subsidiaries, maintains an asset-based revolving credit facility (the "ABL Credit Facility"), which provides for a revolving line of credit up to $1,250 million, including a North American subfacility of up to $950 million and a European subfacility of up to $300 million, subject to borrowing base capacity and certain other restrictions, including a minimum fixed charge coverage ratio. The ABL Credit Facility is set to mature on November 2, 2027, subject to certain springing maturity provisions. Adient will pay a commitment fee of 0.25% to 0.375% on the unused portion of the commitments under the asset-based revolving credit facility based on average global availability. Letters of credit are limited to the lesser of (x) $150 million and (y) the aggregate unused amount of commitments under the ABL Credit Facility then in effect. Subject to certain conditions, the ABL Credit Facility may be expanded by up to $250 million in additional commitments. Loans under the ABL Credit Facility may be denominated, at the option of Adient, in U.S. Dollars, Euros, Pounds Sterling or Swedish Krona. It also provides flexibility for future amendments to the ABL Facility to incorporate certain sustainability-based pricing provisions. The ABL Credit Agreement is secured on a first-priority lien on all accounts receivable, inventory and bank accounts (and funds on deposit therein) and a second-priority lien on all of the tangible and intangible assets of certain Adient subsidiaries. Interest is payable on the ABL Credit Facility at a fluctuating rate of interest determined by reference to Term Secured Overnight Financing Rate (“SOFR”), in the case of amounts outstanding in Dollars, Euro Interbank Offered Rate (“EURIBOR”), in the case of amounts outstanding in Euros, Stockholm Interbank Offered Rate (“STIBOR”), in the case of amounts outstanding in Swedish Krona and Sterling Over Night Indexed Average (“SONIA”), in the case of amounts outstanding in Pounds Sterling, in each case, plus an applicable
margin of 1.50% to 2.00%. As of March 31, 2025, Adient had not drawn down on the ABL Credit Facility and had availability under this facility of $843 million (net of $8 million of letters of credit).

In addition, Adient Global Holdings S.à r.l., a wholly-owned subsidiary of Adient, maintains a senior secured term loan facility (the "Term Loan B Agreement"), that had an outstanding balance of $629 million and $632 million as of March 31, 2025 and September 30, 2024, respectively. During fiscal 2024, the Term Loan B Agreement was amended to reduce the applicable margin from 3.25% to 2.75% and extend final maturity to January 31, 2031. Adient incurred $5 million of costs associated with the modification, of which $4 million was recorded as deferred financing costs. During the first quarter of fiscal 2025, the Term Loan B Agreement was further amended to reduce the applicable margin from 2.75% to 2.25%. Adient incurred $1 million of costs associated with the modification, which was recorded as deferred financing costs. The Term Loan B Agreement amortizes in equal quarterly installments at a rate of 1.00% per annum of the original principal amount thereof, with the remaining balance due at final maturity. The Term Loan B Agreement permits Adient to incur incremental term loans in an aggregate amount not to exceed the greater of $750 million and an unlimited amount subject to a pro forma first lien secured net leverage ratio of not greater than 1.75 to 1.00 and certain other conditions. Interest on the Term Loan B Agreement accrues at Term SOFR plus an applicable margin.

The ABL Credit Facility and Term Loan B Agreement contain covenants that are usual and customary for facilities and debt instruments of this type and that, among other things, restrict the ability of Adient and its restricted subsidiaries to: create certain liens and enter into sale and lease-back transactions; create, assume, incur or guarantee certain indebtedness; pay dividends or make other distributions on, or repurchase or redeem, Adient’s capital stock or certain other debt; make other restricted payments; and consolidate or merge with, or convey, transfer or lease all or substantially all of Adient’s and its restricted subsidiaries’ assets, to another person. These covenants are subject to a number of other limitations and exceptions set forth in the agreements. The agreements also provide for customary events of default, including, but not limited to, cross-default clauses with other debt arrangements, failure to pay principal and interest, failure to comply with covenants, agreements or conditions, and certain events of bankruptcy or insolvency involving Adient and its significant subsidiaries.

Adient Global Holdings Ltd. ("AGH"), a wholly-owned subsidiary of Adient, maintains (i) $500 million in aggregate principal amount of 7.00% senior secured notes due 2028 and (ii) $500 million in aggregate principal amount of 8.250% senior unsecured notes due 2031. Interest on both of these notes is paid on April 15 and October 15 each year, beginning on October 15, 2023. These notes contain covenants that are usual and customary. AGH also maintained $795 million in aggregate principal amount of 4.875% USD-denominated unsecured notes due 2026 as of September 30, 2024. In February 2025, AGH issued $795 million (net proceeds of $783 million) in aggregate principal amount of 7.50% senior unsecured notes. Adient incurred $12 million of costs associated with the transaction, which was recorded as deferred financing costs. Proceeds from the sale of the notes, together with cash on hand, were used to fully redeem AGH's 4.875% senior unsecured notes in March 2025. Upon redemption of the 4.875% notes, Adient wrote off $2 million of previously deferred financing costs associated with the notes to net financing charges. The new notes mature on February 15, 2033 and bear interest at a rate of 7.50% per annum. Interest on the notes is payable semi-annually in arrears on February 15 and August 15 of each year, commencing on August 15, 2025. These notes also contain covenants that are usual and customary.

Net Financing Charges

Adient's net financing charges in the consolidated statements of income (loss) contained the following components:

Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)2025202420252024
Interest expense, net of capitalized interest costs$48 $46 $95 $94 
Banking fees and debt issuance cost amortization11 
Interest income(6)(6)(13)(15)
Net foreign exchange(1)— 
Net financing charges$48 $47 $93 $91 

Banking fees for the three and six months ended March 31, 2025 include $2 million of one-time accelerated-deferred financing fee charges associated with early redemption of the 4.875% notes. Total interest paid on both short and long-term debt for the six months ended March 31, 2025 and 2024 was $84 million and $97 million, respectively.
Other Arrangements

Adient enters into supply chain financing programs in certain domestic and foreign jurisdictions to either sell or discount accounts receivable without recourse to third-party institutions. Sales or discounts of accounts receivable are reflected as a reduction of accounts receivable on the consolidated statements of financial position and the proceeds are included in cash flows from operating activities in the consolidated statements of cash flows. As of March 31, 2025, $170 million was funded under these programs which was a similar amount funded as of September 30, 2024.

Adient also has a program with an external financial institution under which Adient's suppliers can sell their receivables from Adient to the financial institution at their sole discretion. Adient is not a party to the agreements between the participating suppliers and the financial institution. Adient's obligation under the program is to pay the original amounts of supplier invoices to the financial institution on the original invoice dates. No fees are paid and no assets are pledged by Adient. The payment terms for trade payables can range from 45 days to 120 days depending on types of services and goods being purchased. The payment terms for molds, dies and other tools that are acquired as part of pre-production activities are in general longer, and are normally dependent on the terms which Adient has agreed with its customers. As of March 31, 2025, and September 30, 2024, Adient's liabilities related to this program were $91 million and $76 million, respectively. Cash flows related to the program are all presented within operating activities in Adient's consolidated statements of cash flows.
v3.25.1
Derivative Instruments and Hedging Activities
6 Months Ended
Mar. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments and Hedging Activities
9. Derivative Instruments and Hedging Activities

Adient selectively uses derivative instruments to reduce Adient's market risk associated with changes in foreign currency. Under Adient's policy, the use of derivatives is restricted to those intended for hedging purposes; the use of any derivative instrument for speculative purposes is strictly prohibited. A description of each type of derivative utilized to manage Adient's risk is included in the following paragraphs. In addition, refer to Note 10, "Fair Value Measurements," of the notes to the consolidated financial statements for information related to the fair value measurements and valuation methods utilized by Adient for each derivative type.

Adient has global operations and participates in the foreign exchange markets to minimize its risk of loss from fluctuations in foreign currency exchange rates. Adient primarily uses foreign currency exchange contracts to hedge certain foreign exchange rate exposures. Adient hedges 70% to 90% of the nominal amount of each of its known foreign exchange transactional exposures. Gains and losses on derivative contracts offset gains and losses on underlying foreign currency exposures. These contracts have been designated as cash flow hedges under ASC 815, "Derivatives and Hedging," and the hedge gains or losses due to changes in fair value are initially recorded as a component of accumulated other comprehensive income ("AOCI") and are subsequently reclassified into earnings when the hedged transactions occur and affect earnings. All contracts were highly effective in hedging the variability in future cash flows attributable to changes in currency exchange rates at March 31, 2025 and September 30, 2024.

The €123 million aggregate principal amount of 3.50% euro-denominated unsecured notes due 2024 was previously designated as a net investment hedge to selectively hedge portions of Adient's net investment in Europe. The currency effects of Adient's euro-denominated bonds were reflected in the AOCI account within shareholders' equity attributable to Adient where they offset gains and losses recorded on Adient's net investment in Europe. During the first quarter of fiscal 2024, Adient de-designated these notes as a net investment hedge concurrent with entering into a foreign exchange forward contract designated as a fair value hedge of the principal balance on the 3.50% notes. The impact of foreign currency changes on the notes and the contract were recorded in net financing charges until payment of the notes and maturity of the foreign exchange forward contract in August 2024.

During the second quarter of fiscal 2024, Adient entered into a ¥685 million ($96 million) foreign exchange forward contract to selectively hedge portions of its net investment in China. The contract matured during the first quarter of fiscal 2025, the impact of which was not material. During the third quarter of fiscal 2024, Adient entered into an additional ¥570 million ($78 million) contract to selectively hedge portions of its net investment in China. The contract is set to mature in October 2025.
The following table presents the location and fair values of derivative instruments and other amounts used in hedging activities included in Adient's consolidated statements of financial position:

 Derivatives and Hedging
Activities Designated as
Hedging Instruments
under ASC 815
Derivatives and Hedging
Activities Not Designated as
Hedging Instruments
under ASC 815
(in millions)March 31, 2025September 30, 2024March 31, 2025September 30, 2024
Other current assets
Foreign currency exchange derivatives$10 $$$
Other noncurrent assets
Foreign currency exchange derivatives— 
Total assets$11 $10 $$
Other current liabilities
Foreign currency exchange derivatives$21 $32 $— $— 
Other noncurrent liabilities
Foreign currency exchange derivatives— — 
Total liabilities$23 $41 $— $— 

Adient enters into International Swaps and Derivatives Associations ("ISDA") master netting agreements with counterparties that permit the net settlement of amounts owed under the derivative contracts. The master netting agreements generally provide for net settlement of all outstanding contracts with a counterparty in the case of an event of default or a termination event. Adient has not elected to offset the fair value positions of the derivative contracts recorded in the consolidated statements of financial position. Collateral is generally not required of Adient or the counterparties under the master netting agreements. As of March 31, 2025 and September 30, 2024, no cash collateral was received or pledged under the master netting agreements.

The gross and net amounts of derivative instruments and other amounts used in hedging activities are as follows:

AssetsLiabilities
(in millions)March 31, 2025September 30, 2024March 31, 2025September 30, 2024
Gross amount recognized$12 $18 $23 $41 
Gross amount eligible for offsetting(9)(9)(9)(9)
Net amount$$$14 $32 

The following table presents the effective portion of pretax gains (losses) recorded in other comprehensive income related to cash flow hedges:

Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)2025202420252024
Foreign currency exchange derivatives$13 $12 $(1)$38 
The following table presents the location and amount of the effective portion of pretax gains (losses) on cash flow hedges reclassified from AOCI into Adient's consolidated statements of income (loss):
(in millions)Three Months Ended
March 31,
Six Months Ended
March 31,
2025202420252024
Foreign currency exchange derivativesCost of sales$(9)$18 $(17)$33 
During the next twelve months, $11 million of pretax losses on cash flow hedges are expected to be reclassified from AOCI into Adient's consolidated statements of income (loss).

The following table presents the location and amount of pretax gains (losses) on fair value hedge activity in Adient's consolidated statements of income (loss):
(in millions)Three Months Ended
March 31,
Six Months Ended
March 31,
2025202420252024
Foreign currency exchange derivativesNet financing charges$— $(3)$— $
The following table presents the location and amount of pretax gains (losses) on derivatives not designated as hedging instruments recognized in Adient's consolidated statements of income (loss):

(in millions)Three Months Ended
March 31,
Six Months Ended
March 31,
2025202420252024
Foreign currency exchange derivativesCost of sales$$(2)$— $(1)
Foreign currency exchange derivativesNet financing charges(1)(8)(14)
Total$$(10)$(14)$— 

The effective portion of pretax gains (losses) recorded in currency translation adjustment ("CTA") within other comprehensive income (loss) related to net investment hedges was $(1) million and $1 million for the three months ended March 31, 2025 and 2024, respectively and $3 million and $(1) million for the six months ended March 31, 2025 and 2024, respectively. For the three and six months ended March 31, 2025 and 2024, no gains or losses were reclassified from CTA into income for Adient's outstanding net investment hedges.

For the three and six months ended March 31, 2025 and 2024, no ineffectiveness was recognized in the consolidated statements of income (loss) resulting from cash flow hedges.
v3.25.1
Fair Value Measurements
6 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Fair Value Measurements
10. Fair Value Measurements

ASC 820, "Fair Value Measurement," defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also establishes a three-level fair value hierarchy that prioritizes information used in developing assumptions when pricing an asset or liability as follows:
Level 1: Observable inputs such as quoted prices in active markets;
Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and
Level 3: Unobservable inputs where there is little or no market data, which requires the reporting entity to develop its own assumptions.
ASC 820 requires the use of observable market data, when available, in making fair value measurements. When inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement.
Recurring Fair Value Measurements

The following tables present Adient's fair value hierarchy for those assets and liabilities measured at fair value:

 Fair Value Measurements Using:
(in millions)
Total as of
March 31, 2025
Quoted Prices
in Active
Markets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Other current assets
Foreign currency exchange derivatives$11 $— $11 $— 
Other noncurrent assets
Foreign currency exchange derivatives— — 
Total assets$12 $— $12 $— 
Other current liabilities
Foreign currency exchange derivatives$21 — $21 — 
Other noncurrent liabilities
Foreign currency exchange derivatives— — 
Total liabilities$23 $— $23 $— 

Fair Value Measurements Using:
(in millions)
Total as of
September 30, 2024
Quoted Prices
in Active
Markets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Other current assets
Foreign currency exchange derivatives$15 $— $15 $— 
Other noncurrent assets
Foreign currency exchange derivatives— — 
Total assets$18 $— $18 $— 
Other current liabilities
Foreign currency exchange derivatives$32 $— $32 $— 
Other noncurrent liabilities
Foreign currency exchange derivatives— — 
Total liabilities$41 $— $41 $— 

Valuation Methods
Foreign currency exchange derivatives: Adient selectively hedges anticipated transactions and net investments that are subject to foreign exchange rate risk primarily using foreign currency exchange hedge contracts. The foreign currency exchange derivatives are valued under a market approach using publicized spot and forward prices. Changes in fair value on foreign exchange derivatives accounted for as hedging instruments under ASC 815 are initially recorded as a component of AOCI and are subsequently reclassified into earnings when the hedged transactions occur and affect earnings. These contracts were highly effective in hedging the variability in future cash flows attributable to changes in currency exchange rates at March 31, 2025 and September 30, 2024, respectively. The changes in fair value of foreign currency exchange derivatives not designated as hedging instruments under ASC 815 are recorded in the consolidated statements of income (loss).

The fair value of cash and cash equivalents, accounts receivable, short-term debt and accounts payable approximate their carrying values. The fair value of long-term debt, which was $2.3 billion and $2.4 billion at March 31, 2025 and September 30,
2024, respectively, was determined primarily using market quotes classified as Level 1 inputs within the ASC 820 fair value hierarchy.
v3.25.1
Equity and Noncontrolling Interests
6 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Equity and Noncontrolling Interests
11. Equity and Noncontrolling Interests

For the three months ended March 31, 2025:

(in millions)Ordinary SharesAdditional Paid-in CapitalRetained Earnings
(Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)Shareholders' Equity Attributable
 to Adient
Shareholders' Equity Attributable to Noncontrolling InterestsTotal Equity
Balance at December 31, 2024$ $3,682 $(885)$(920)$1,877 $284 $2,161 
Net income (loss)— — (335)— (335)14 (321)
Foreign currency translation adjustments— — — 89 89 93 
Realized and unrealized gains on derivatives— — — 17 17 — 17 
Dividends attributable to noncontrolling interests— — — —  (5)(5)
Share based compensation and other— — — 4 — 4 
Balance at March 31, 2025
$ $3,686 $(1,220)$(814)$1,652 $297 $1,949 

For the six months ended March 31, 2025:

(in millions)Ordinary SharesAdditional Paid-in CapitalRetained Earnings
(Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)Shareholders' Equity Attributable
 to Adient
Shareholders' Equity Attributable to Noncontrolling InterestsTotal Equity
Balance at September 30, 2024$ $3,712 $(885)$(693)$2,134 $309 $2,443 
Net income (loss)— — (335)— (335)29 (306)
Foreign currency translation adjustments— — — (128)(128)(7)(135)
Realized and unrealized gains on derivatives— — — 9 — 9 
Dividends attributable to noncontrolling interests— — — —  (15)(15)
Purchase of noncontrolling interest (1)
— (7)— (2)(9)(19)(28)
Repurchases of common stock— (25)— — (25)— (25)
Share based compensation and other— — — 6 — 6 
Balance at March 31, 2025
$ $3,686 $(1,220)$(814)$1,652 $297 $1,949 

(1) Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for additional information.
For the three months ended March 31, 2024:

(in millions)Ordinary SharesAdditional Paid-in CapitalRetained Earnings
(Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)Shareholders' Equity Attributable
 to Adient
Shareholders' Equity Attributable to Noncontrolling InterestsTotal Equity
Balance at December 31, 2023$ $3,872 $(883)$(704)$2,285 $331 $2,616 
Net income (loss)— — (70)— (70)14 (56)
Foreign currency translation adjustments— — — (92)(92)(4)(96)
Realized and unrealized losses on derivatives— — — (6)(6)— (6)
Dividends attributable to noncontrolling interests— — — —  (14)(14)
Repurchases of common stock— (50)— — (50)— (50)
Share based compensation and other— — — 8 — 8 
Balance at March 31, 2024
$ $3,830 $(953)$(802)$2,075 $327 $2,402 

For the six months ended March 31, 2024:

(in millions)Ordinary SharesAdditional Paid-in CapitalRetained Earnings
(Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)Shareholders' Equity Attributable
 to Adient
Shareholders' Equity Attributable to Noncontrolling InterestsTotal Equity
Balance at September 30, 2023$ $3,973 $(903)$(842)$2,228 $318 $2,546 
Net income (loss)— — (50)— (50)26 (24)
Foreign currency translation adjustments— — — 37 37 38 
Realized and unrealized gains on derivatives— — — 3 — 3 
Dividends attributable to noncontrolling interests— — — —  (18)(18)
Repurchases of common stock— (150)— — (150)— (150)
Share based compensation and other— — — 7 — 7 
Balance at March 31, 2024
$ $3,830 $(953)$(802)$2,075 $327 $2,402 

The following table presents changes in AOCI attributable to Adient:

Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)2025202420252024
Foreign currency translation adjustments
Balance at beginning of period$(892)$(725)$(673)$(854)
Aggregate adjustment for the period, net of tax89 (92)(130)37 
Balance at end of period (1)
$(803)$(817)$(803)$(817)
Realized and unrealized gains (losses) on derivatives
Balance at beginning of period$(27)$22 $(19)$13 
Current period changes in fair value, net of tax11 (3)29 
Reclassification to income, net of tax(14)12 (26)
Balance at end of period$(10)$16 $(10)$16 
Pension and postretirement plans
Balance at beginning of period$(1)$(1)$(1)$(1)
Balance at end of period$(1)$(1)$(1)$(1)
Accumulated other comprehensive loss, end of period$(814)$(802)$(814)$(802)
(1) Foreign currency translation adjustments as of March 31, 2025 and 2024 include gains on designated net investment hedge instruments of $0 million and $1 million, respectively. During the next twelve months, no gains or losses are expected to be reclassified from AOCI into Adient's consolidated statements of income (loss).

Adient consolidates certain subsidiaries in which the noncontrolling interest party has within their control the right to require Adient to redeem all or a portion of its interest in the subsidiary. These redeemable noncontrolling interests are reported at their estimated redemption value. Any adjustment to the redemption value impacts retained earnings but does not impact net income. Redeemable noncontrolling interests which are redeemable only upon future events, the occurrence of which is not currently probable, are recorded at carrying value. The following table presents changes in the redeemable noncontrolling interests:

Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)2025202420252024
Beginning balance$62 $57 $91 $57 
Net income (1)
18 20 
Dividends— — (31)(21)
Foreign currency translation adjustments(6)(7)
Ending balance$71 $58 $71 $58 

(1) During the six months ended March 31, 2024, a $5 million adjustment was recorded to increase income attributable to noncontrolling interest related to fiscal 2023.

Repurchases of Equity Securities

In November 2022, Adient’s board of directors authorized the repurchase of Adient's ordinary shares up to an aggregate purchase price of $600 million with no expiration date. Under the share repurchase authorization, Adient’s ordinary shares may be purchased either through discretionary purchases on the open market, by block trades or privately negotiated transactions. The number of ordinary shares repurchased, if any, and the timing of repurchases will depend on a number of factors, including share price, trading volume and general market conditions, as well as on working capital requirements, general business conditions and other factors. During fiscal 2024, Adient repurchased and immediately retired 9,424,668 of its ordinary shares at an average purchase price per share of $29.18. The aggregate amount of cash paid to repurchase the shares was $275 million, of which $150 million had been spent through March 31, 2024. During the six months ended March 31, 2025, Adient repurchased and immediately retired 1,227,329 of its ordinary shares at an average purchase price per share of $20.37. The aggregate amount of cash paid to repurchase shares was $25 million, all of which had been spent as of December 31, 2024. As of March 31, 2025, the remaining aggregate amount of authorization remaining under the share repurchase authorization was $235 million.
v3.25.1
Retirement Plans
6 Months Ended
Mar. 31, 2025
Retirement Benefits [Abstract]  
Retirement Plans
12. Retirement Plans

Adient maintains non-contributory defined benefit pension plans covering primarily non-U.S. employees and a limited number of U.S. employees. The following table contains the components of net periodic benefit cost:

Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)2025202420252024
Service cost$$$$
Interest cost10 
Expected return on plan assets(4)(3)(7)(6)
Net periodic benefit cost$$$$

The interest cost, expected return on plan assets, and net actuarial and settlement/curtailment (gain) loss components of net periodic benefit cost are included in other pension expense in the consolidated statements of income (loss).
v3.25.1
Restructuring and Impairment Costs
6 Months Ended
Mar. 31, 2025
Restructuring and Related Activities [Abstract]  
Restructuring and Impairment Costs
13. Restructuring and Impairment Costs

Restructuring
To better align its resources with its overall strategies and reduce the cost structure of its global operations to address the softness in certain underlying markets, Adient commits to restructuring plans as necessary. Adient, in general, records costs associated with separation programs when management has approved the plan for separation, the affected employees are identified, and it is unlikely that actions required to complete the separation plan will change significantly. Costs associated with benefits that are contingent on the employee continuing to provide service are accrued over the required service period. All other costs associated with restructuring activities are expensed as incurred.

During the first six months of fiscal 2025, Adient committed to restructuring actions ("2025 Plan") resulting in charges of $33 million, which was offset by $2 million of prior-year underspend. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions in EMEA. The 2025 Plan is being implemented in response to manufacturing footprint and structural changes occurring in the global automotive industry and to ensure Adient maintains a competitive cost structure by reducing operating, administrative and engineering costs, and increasing efficiencies. Restructuring actions associated with these specific plans will primarily occur in fiscal years 2025 and 2026 and are expected to be substantially complete by fiscal year 2027. Restructuring costs are included in restructuring and impairment costs in the consolidated statements of income (loss). The following tables summarize the changes in Adient's restructuring reserve.

For the three months ended March 31, 2025:

(in millions)Employee Severance and Termination BenefitsCurrency
Translation
Total
Balance at December 31, 2024$165 $(11)$154 
2025 Plan charges24 — 24 
Utilized - cash(28)— (28)
Noncash and other adjustments(6)
Balance at March 31, 2025
$155 $(3)$152 
Current restructuring reserve - other current liabilities$91 
Noncurrent restructuring reserve - other noncurrent liabilities61 
Balance at March 31, 2025$152 

For the six months ended March 31, 2025:

(in millions)Employee Severance and Termination BenefitsCurrency
Translation
Total
Balance at September 30, 2024$181 $$182 
2025 Plan charges33 — 33 
Utilized - cash(57)— (57)
Noncash and other adjustments(2)(4)(6)
Balance at March 31, 2025
$155 $(3)$152 

During the first six months of fiscal 2024, Adient committed to restructuring actions ("2024 Plan") resulting in charges of $138 million, including a charge of $127 million recorded during the three months ended March 31, 2024, which was offset by $2 million of prior-year underspend. The second quarter charges were almost entirely related to termination benefits in Europe. The 2024 Plan was implemented in response to structural changes occurring in the European automotive market and to ensure Adient maintains a competitive cost structure by reducing operating, administrative and engineering costs, and increasing efficiencies. Restructuring actions associated with these specific plans primarily occur in fiscal years 2025 and 2026 and are
expected to be substantially complete by fiscal year 2027. Restructuring costs are included in restructuring and impairment costs in the consolidated statements of income (loss).

For the three months ended March 31, 2024:

(in millions)Employee Severance and Termination BenefitsCurrency
Translation
Total
Balance at December 31, 2023$58 $(4)$54 
2024 Plan charges127 — 127 
Utilized - cash(8)— (8)
Noncash and other adjustments(2)(2)(4)
Balance at March 31, 2024$175 $(6)$169 
Current restructuring reserve - other current liabilities$64 
Noncurrent restructuring reserve - other noncurrent liabilities105 
Balance at March 31, 2024$169 

For the six months ended March 31, 2024:

(in millions)Employee Severance and Termination BenefitsCurrency
Translation
Total
Balance at September 30, 2023$56 $(5)$51 
2024 Plan charges138 — 138 
Utilized - cash(17)— (17)
Noncash and other adjustments(2)(1)(3)
Balance at March 31, 2024$175 $(6)$169 

Adient's management closely monitors its overall cost structure and continually analyzes each of its businesses for opportunities to consolidate current operations, improve operating efficiencies and locate facilities in low-cost countries in close proximity to customers. This ongoing analysis includes a review of its manufacturing, engineering, purchasing and administrative functions, as well as the overall global footprint for all its businesses. Future adverse developments in the automotive industry could impact Adient's liquidity position, lead to impairment charges and/or require additional restructuring of its operations.

Impairment
During the first six months of fiscal 2025, Adient recorded a non-cash impairment loss of $10 million on its investment in Adient Aerospace. The impairment is included in restructuring and impairment costs in the consolidated statements of income (loss). Refer also to Note 5, "Goodwill and Other Intangible Assets" of the notes to the consolidated financial statements for information about a goodwill impairment recorded during the three months ended March 31, 2025.
v3.25.1
Income Taxes
6 Months Ended
Mar. 31, 2025
Income Tax Disclosure [Abstract]  
Income Taxes
14. Income Taxes

In calculating the provision for income taxes, Adient uses an estimate of the annual effective tax rate based upon the facts and circumstances known at each interim period. On a quarterly basis, the actual effective tax rate is adjusted, as appropriate, based on changes in facts and circumstances, if any, as compared to those forecasted at the beginning of the fiscal year and each interim period thereafter. For the three and six months ended March 31, 2025, Adient’s income tax expense was $48 million equating to an effective tax rate of (18)% and $70 million equating to an effective tax rate of (32)%, respectively. The three month income tax expense was higher than the Irish statutory rate of 12.5% primarily due to the inability to record a tax benefit for losses in jurisdictions with valuation allowances, tax expense related to adjustments to net operating loss deferred tax assets and uncertain tax positions, and the impact of the impairment of the non-tax-deductible portion of the EMEA goodwill balance
for which there is no corresponding income tax benefit. The six month income tax expense was higher than the Irish statutory rate of 12.5% primarily due to the inability to record a tax benefit for losses in jurisdictions with valuation allowances, tax expense related to adjustments to net operating loss deferred tax assets and uncertain positions, and the impact of the impairment of the non-tax-deductible portion of the EMEA goodwill balance for which there is no corresponding income tax benefit, partially offset by tax benefits from the release of uncertain tax positions due to statute lapses. For the three and six months ended March 31, 2024, Adient’s income tax expense was $8 million equating to an effective tax rate of (20)% and $28 million equating to an effective tax rate of 117%, respectively. The three and six month income tax expense was higher than the Irish statutory rate of 12.5% primarily due to the inability to record a tax benefit for losses in jurisdictions with valuation allowances, partially offset by tax benefits from the release of uncertain tax positions due to audit closures.

Valuation Allowances

As a result of Adient's second quarter fiscal 2025 analysis of the realizability of its worldwide deferred tax assets, and after considering tax planning initiatives and other positive and negative evidence, Adient determined that no changes to valuation allowances were required.

Adient reviews the realizability of its deferred tax assets on a quarterly basis, or whenever events or changes in circumstances indicate that a review is required. In determining the requirement for a valuation allowance, the historical and projected financial results of the legal entity or combined group recording the net deferred tax asset are considered, along with any other positive or negative evidence. All of the factors that Adient considers in evaluating whether and when to establish or release all or a portion of the deferred tax asset valuation allowance involve significant judgment. Since future financial results may differ from previous estimates, periodic adjustments to Adient's valuation allowances may be necessary.

Given current earnings and anticipated future earnings at certain subsidiaries, Adient believes that there is a reasonable possibility that sufficient positive evidence may become available that would allow the release of all, or a portion of, valuation allowances at certain subsidiaries within the next twelve months. A release of valuation allowances, if any, would result in the recognition of certain deferred tax assets which could generate a material income tax benefit for the period in which such release is recorded.

Uncertain Tax Positions

At March 31, 2025, Adient had gross tax effected unrecognized tax benefits of $418 million. If recognized, $111 million of Adient's unrecognized tax benefits would impact the effective tax rate. Total net accrued interest at March 31, 2025 was approximately $20 million (net of tax benefit). The interest and penalties accrued for the three and six months ended March 31, 2025 was $1 million and $1 million, respectively. Additionally, during the three months ended March 31, 2025, Adient recognized tax expense of $9 million to establish a reserve for an uncertain tax position. During the six months ended March 31, 2025, Adient recognized tax benefits of $7 million related to the release of uncertain tax positions due to statute lapses as well as tax expense of $9 million to establish a reserve for an uncertain tax position. At September 30, 2024, Adient had gross tax effected unrecognized tax benefits of $422 million. If recognized, $106 million of Adient's unrecognized tax benefits would impact the effective tax rate. Total net accrued interest at September 30, 2024 was approximately $21 million (net of tax benefit). The interest and penalties accrued for the three and six months ended March 31, 2024 was $1 million and $3 million, respectively. Adient recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense.

Other

During the three and six months ended March 31, 2025, Adient recognized tax expense of $19 million related to adjustments to net operating loss deferred tax assets. In addition, Adient recognized a tax benefit from the write-off of a $13 million deferred tax liability associated with the tax-deductible portion of the EMEA goodwill balance which was impaired during the three months ended March 31, 2025.
The Organization for Economic Cooperation and Development’s Pillar Two initiative, which introduced a 15% global minimum tax applied on a country by country basis, is applicable for Adient’s fiscal 2025. Adient has estimated the annual effect of these new rules and the impact on Adient’s effective tax rate is not material. Adient will continue to monitor and evaluate new legislation and guidance related to Pillar Two, which could change our current assessment.
v3.25.1
Segment Information
6 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Segment Information
15. Segment Information

Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: (i) Americas, which is inclusive of North America and South America; (ii) Europe, Middle East, and Africa ("EMEA"); and (iii) Asia Pacific/China ("Asia").

Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income (loss) before income taxes and noncontrolling interests, excluding net financing charges, restructuring and impairment costs, restructuring related-costs, net mark-to-market adjustments on pension and postretirement plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items ("Adjusted EBITDA"). Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker.

The following table summarizes net sales and adjusted EBITDA by reportable segment for the three and six months ended March 31, 2025 and 2024:

(in millions)AmericasEMEAAsiaCorporate/EliminationsConsolidated
Three months ended March 31, 2025
Net sales$1,699 $1,231 $707 $(26)$3,611 
Adjusted EBITDA$94 $50 $110 $(21)$233 
Six months ended March 31, 2025
Net sales$3,310 $2,360 $1,479 $(43)$7,106 
Adjusted EBITDA$179 $72 $221 $(43)$429 
Three months ended March 31, 2024
Net sales$1,660 $1,370 $742 $(22)$3,750 
Adjusted EBITDA$80 $57 $112 $(22)$227 
Six months ended March 31, 2024
Net sales$3,307 $2,638 $1,512 $(47)$7,410 
Adjusted EBITDA$160 $102 $226 $(45)$443 
The following is a reconciliation of Adient's reportable segments' adjusted EBITDA to income (loss) before income taxes:

Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)2025202420252024
Adjusted EBITDA
Americas$94 $80 $179 $160 
EMEA50 57 72 102 
Asia110 112 221 226 
Subtotal254 249 472 488 
Corporate-related costs (1)
(21)(22)(43)(45)
Restructuring and impairment costs (2)
(351)(125)(374)(136)
Purchase accounting amortization (3)
(12)(13)(23)(24)
Restructuring related charges (4)
(5)(2)(6)
Gain (loss) on disposal transactions (5)
— — (8)
Depreciation
(67)(70)(136)(142)
Equity based compensation (6)
(5)(10)(10)(23)
Other items (7)
(9)(7)
Earnings before interest and income taxes(216)(123)119 
Net financing charges(48)(47)(93)(91)
Other pension expense(1)(2)(2)(4)
Income (loss) before income taxes$(265)$(41)$(218)$24 

Notes:

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.
(2) Reflects restructuring charges for costs that are probable and reasonably estimable and non-recurring asset impairments. The three months ended March 31, 2025 reflects restructuring charges of $18 million, and a non-recurring, non-cash goodwill impairment charge of $333 million in the EMEA reporting unit. The six months ended March 31, 2025 reflects restructuring charges of $31 million, a non-recurring, non-cash goodwill impairment charge of $333 million in the EMEA reporting unit, and an impairment charge of $10 million related to Adient’s investment in Adient Aerospace. Refer to Note 5, "Goodwill and Other Intangible Assets" and Note 13, "Restructuring and Impairment Costs" of the notes to the consolidated financial statements for additional information.
(3) Reflects amortization of intangible assets including those related to partially-owned affiliates recorded within equity income.
(4) Reflects restructuring-related charges for costs that are recorded as incurred or as earned and other non-recurring impacts that are directly attributable to restructuring activities. The six months ended March 31, 2025 and 2024 include a $5 million and a $10 million gain on sale of restructured facilities, respectively.
(5) The six months ended March 31, 2025 reflects a $4 million gain on sale of Adient's partially-owned investment in Setex. The six months ended March 31, 2024 reflects an $8 million loss on sale of 51% of Adient's interest in LFADNT. Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for additional information.
(6) During the six months ended March 31, 2024, a $5 million adjustment was recorded to increase equity-based compensation expense related to a retired executive's equity awards that should have been recognized in periods prior to fiscal 2023.
(7) The three months ended March 31, 2025 includes $8 million of third-party consulting costs associated with strategic planning and a $1 million non-recurring loss at affiliates. The six months ended March 31, 2025 includes $8 million of third-party consulting costs associated with strategic planning and a $1 million non-recurring loss at affiliates, partially offset by a
$2 million gain on a non-recurring contract related settlement. The three months ended March 31, 2024 reflects $1 million of indirect tax recoveries in Brazil. The six months ended March 31, 2024 includes a $3 million non-recurring gain on a contract related settlement and $1 million of indirect tax recoveries in Brazil, partially offset by $2 million one-time divestiture related tax impact at an affiliate.

Geographic Information

Revenue by geographic area is as follows:

Net Sales
 Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)2025202420252024
Americas
United States$1,565 $1,491 $3,010 $2,913 
Mexico606 628 1,214 1,260 
Other Americas70 61 145 147 
Regional elimination(542)(520)(1,059)(1,013)
1,699 1,660 3,310 3,307 
EMEA
Germany242 254 451478 
Poland214 249 415 498 
Czech Republic180 220 356 415 
Spain179 206 360 386 
Sweden142 157 281 309 
Other EMEA579 658 1,089 1,275 
Regional elimination(305)(374)(592)(723)
1,231 1,370 2,360 2,638 
Asia
China286 336 621 710 
Thailand131 126 254 248 
Korea126 128 273 250 
Japan106 86 213 179 
Other Asia74 78 152 149 
Regional elimination(16)(12)(34)(24)
707 742 1,479 1,512 
Inter-segment elimination(26)(22)(43)(47)
Total$3,611 $3,750 $7,106 $7,410 
v3.25.1
Nonconsolidated Partially-Owned Affiliates
6 Months Ended
Mar. 31, 2025
Equity Method Investments and Joint Ventures [Abstract]  
Nonconsolidated Partially-Owned Affiliates
16. Nonconsolidated Partially-Owned Affiliates

Investments in the net assets of nonconsolidated partially-owned affiliates are reported in the investments in partially-owned affiliates line in the consolidated statements of financial position as of March 31, 2025 and September 30, 2024. Equity in the net income of nonconsolidated partially-owned affiliates are reported in the equity income line in the consolidated statements of income (loss) for the three and six months ended March 31, 2025 and 2024, respectively.
Adient maintains total investments in partially-owned affiliates of $293 million and $338 million at March 31, 2025 and September 30, 2024, respectively. Operating information for nonconsolidated partially-owned affiliates is as follows:

Six Months Ended
March 31,
(in millions)20252024
Income statement data:
Net sales$1,819 $1,938 
Gross profit$159 $204 
Net income$80 $89 
Net income attributable to the entity$78 $88 

Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for transactions involving Adient's investments in nonconsolidated partially-owned affiliates.
v3.25.1
Commitments and Contingencies
6 Months Ended
Mar. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
17. Commitments and Contingencies

Adient is involved in various lawsuits, claims and proceedings incident to the operation of its businesses, including those pertaining to product liability, casualty environmental, safety and health, intellectual property, employment, trade and other regulatory compliance, commercial and contractual matters, and various other matters. Although the outcome of any such lawsuit, claim or proceeding cannot be predicted with certainty and some may be disposed of unfavorably to Adient, it is management's opinion that none of these will have a material adverse effect on Adient's financial position, results of operations or cash flows. Costs related to such matters were not material to the periods presented.

Adient accrues for potential environmental liabilities when it is probable a liability has been incurred and the amount of the liability is reasonably estimable. Reserves for environmental liabilities totaled $2 million and $3 million at March 31, 2025 and September 30, 2024, respectively. Adient reviews the status of its environmental sites on a quarterly basis and adjusts its reserves accordingly. Such potential liabilities accrued by Adient do not take into consideration possible recoveries of future insurance proceeds. They do, however, take into account the likely share other parties will bear at remediation sites. It is difficult to estimate Adient's ultimate level of liability at many remediation sites due to the large number of other parties that may be involved, the complexity of determining the relative liability among those parties, the uncertainty as to the nature and scope of the investigations and remediation to be conducted, the uncertainty in the application of law and risk assessment, the various choices and costs associated with diverse technologies that may be used in corrective actions at the sites, the often quite lengthy periods over which eventual remediation may occur, and changing environmental laws. Nevertheless, Adient does not currently believe that any claims, penalties or costs in connection with known environmental matters will have a material adverse effect on Adient's financial position, results of operations or cash flows.
v3.25.1
Related Party Transactions
6 Months Ended
Mar. 31, 2025
Related Party Transactions [Abstract]  
Related Party Transactions
18. Related Party Transactions

In the ordinary course of business, Adient enters into transactions with related parties, such as equity affiliates. Such transactions consist of the sale or purchase of goods and other arrangements.

The following table sets forth the net sales to and purchases from related parties included in the consolidated statements of income (loss):

Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)2025202420252024
Net sales to related partiesNet sales$28 $65 $84 $131 
Purchases from related partiesCost of sales76 110 159 213 
The following table sets forth the amount of accounts receivable due from and payable to related parties in the consolidated statements of financial position:

(in millions)March 31, 2025September 30, 2024
Receivables from related partiesAccounts receivable$12 $28 
Payables to related partiesAccounts payable/other current liabilities21 114 
v3.25.1
Pay vs Performance Disclosure - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Pay vs Performance Disclosure        
Net Income (Loss) $ (335) $ (70) $ (335) $ (50)
v3.25.1
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.1
Organization and Summary of Significant Accounting Policies (Policies)
6 Months Ended
Mar. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation
The unaudited consolidated financial statements of Adient have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission and in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). These interim consolidated financial statements include all adjustments (consisting of normal recurring adjustments) that management believes are necessary for a fair statement of the results of operations, financial position and cash flows of Adient for the interim periods presented. Certain figures for comparative periods were regrouped to conform to current period presentation.
Principles of Consolidations
Principles of Consolidation
Adient consolidates its wholly-owned subsidiaries and those entities in which it has a controlling interest. Investments in partially-owned affiliates are accounted for by the equity method when Adient's interest exceeds 20% and does not have a controlling interest.
Consolidated VIEs
Consolidated VIEs
Based upon the criteria set forth in the Financial Accounting Standards Board (the "FASB") Accounting Standards Codification ("ASC") 810, "Consolidation," Adient has determined that it was the primary beneficiary in two variable interest entities ("VIEs") for the reporting periods ended March 31, 2025, and September 30, 2024, as Adient absorbs significant economics of the entities and has the power to direct the activities that are considered most significant to the entities.
The two VIEs manufacture seating products in North America for the automotive industry. Adient funds the entities' short-term liquidity needs through revolving credit facilities and has the power to direct the activities that are considered most significant to the entities through its key customer supply relationships.
New Accounting Pronouncements
New Accounting Pronouncements

Standards to be Adopted During Fiscal 2025

Adient will adopt Accounting Standards Codification ("ASU") 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures in fiscal 2025 which requires additional disclosures on significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss (collectively referred to as the “significant expense principle”). The ASU also requires additional disclosures of an amount for other segment items by reportable segment and a description of its composition. The new guidance will be applied retrospectively in Adient's fiscal 2025 annual filing on Form 10-K and in subsequent quarterly filings on Form 10-Q. The adoption of this guidance is expected to result in incremental segment information disclosures within the footnotes to the consolidated financial statements.

Standards Effective After Fiscal 2025

Adient has considered the new standards that are summarized below, each to be effective after fiscal 2025:

Standard to be AdoptedDescriptionDate Effective
ASU 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures.The ASU requires disclosure of additional details about the reporting entity's reconciliation of the effective tax rate to the statutory rate for federal, state, and foreign income taxes. The ASU also requires further disaggregation of income tax amounts paid by federal, state and foreign, as well as by material jurisdiction.October 1, 2025
ASU 2024-03 Income Statement - Reporting Comprehensive
Income - Expense: Disaggregation Disclosures
(Subtopic 220-40)
The ASU requires disclosures of specified information about certain costs and expenses in the notes to financial statements at each interim and annual reporting period, including: the amounts of purchases of inventory, employee compensation, depreciation, intangible asset amortization, and a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. It also requires disclosures of the total amount of selling expenses and, in annual reporting periods, an entity’s definition of selling expenses.October 1, 2027
Revenue Recognition
Adient generates revenue through the sale of automotive seating solutions, including complete seating systems and the components of complete seating systems. Adient provides production and service parts to its customers under awarded multi-year programs. The duration of a program is generally consistent with the life cycle of a vehicle; however, the program can be canceled at any time without cause by the customer. Programs awarded to Adient to supply parts to its customers do not contain a firm commitment by the customer for volume or price and do not reach the level of a performance obligation until Adient receives either a purchase order and/or a materials release from the customer for a specific number of parts at a specified price, at which point an enforceable contract exists. Sales revenue is generally recognized at the point in time when parts are shipped and control has transferred to the customer, at which point an enforceable right to payment exists. Contracts may provide for annual price reductions over the production life of the awarded program, and prices are adjusted on an ongoing basis to reflect changes in product content/cost and other commercial factors. The amount of revenue recognized reflects the consideration that Adient expects to be entitled to in exchange for such products based on purchase orders, annual price reductions and ongoing price adjustments (some of which are accounted for as variable consideration and subject to being constrained), net of the impact, if any, of consideration paid to the customer. Approximately 2% of net sales recorded during the second quarter of fiscal 2025 were related to product sales transacted in prior periods.
In pursuit of new program awards, Adient at times agrees to make upfront payments to customers. Each time such a payment is made, Adient evaluates its nature, the underlying economics, legal and compliance ramifications, and other relevant factors and circumstances. These payments are deemed to be consideration payable to customers and are generally recognized as a reduction to revenue once mutually agreed. Certain upfront payments, however, are capitalized as other current and noncurrent assets if they are determined to be incremental, attributable only to the specific new program being awarded, and recoverable. As products under the new program are sold to the customer, the capitalized amount is amortized and recognized as a reduction to revenue over the term of the program, typically between three and seven years. Adient assesses recoverability of the capitalized amounts on an on-going basis. Any amounts that are concluded to be no longer recoverable are immediately recognized as a reduction to revenue.
v3.25.1
Organization and Summary of Significant Accounting Policies (Tables)
6 Months Ended
Mar. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Carrying Amounts and Classifications of Assets and Liabilities for Consolidated VIEs
The carrying amounts and classification of assets (none of which is restricted) and liabilities included in Adient's consolidated statements of financial position for the consolidated VIEs are as follows:

(in millions)March 31, 2025September 30, 2024
Current assets$309 $285 
Noncurrent assets95 98 
Total assets$404 $383 
Current liabilities$267 $241 
Noncurrent liabilities11 12 
Total liabilities$278 $253 
Schedule of Computation of Basic and Diluted Earnings Per Share
The following table reconciles the numerators and denominators used to calculate basic and diluted loss per share:
Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions, except per share data)2025202420252024
Income available to shareholders
Net loss attributable to Adient$(335)$(70)$(335)$(50)
Weighted average shares outstanding
Basic weighted average shares outstanding84.0 90.5 84.2 91.7 
Effect of dilutive securities:
Stock options, unvested restricted stock and unvested performance share awards— — — — 
Diluted weight average shares outstanding84.0 90.5 84.2 91.7 
Loss per share:
Basic$(3.99)$(0.77)$(3.98)$(0.55)
Diluted$(3.99)$(0.77)$(3.98)$(0.55)
Schedule of New Accounting Pronouncements
Adient has considered the new standards that are summarized below, each to be effective after fiscal 2025:

Standard to be AdoptedDescriptionDate Effective
ASU 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures.The ASU requires disclosure of additional details about the reporting entity's reconciliation of the effective tax rate to the statutory rate for federal, state, and foreign income taxes. The ASU also requires further disaggregation of income tax amounts paid by federal, state and foreign, as well as by material jurisdiction.October 1, 2025
ASU 2024-03 Income Statement - Reporting Comprehensive
Income - Expense: Disaggregation Disclosures
(Subtopic 220-40)
The ASU requires disclosures of specified information about certain costs and expenses in the notes to financial statements at each interim and annual reporting period, including: the amounts of purchases of inventory, employee compensation, depreciation, intangible asset amortization, and a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. It also requires disclosures of the total amount of selling expenses and, in annual reporting periods, an entity’s definition of selling expenses.October 1, 2027
v3.25.1
Inventories (Tables)
6 Months Ended
Mar. 31, 2025
Inventory Disclosure [Abstract]  
Schedule of Inventories
Inventories consisted of the following:

(in millions)March 31, 2025September 30, 2024
Raw materials and supplies$550 $582 
Work-in-process29 29 
Finished goods140 147 
Inventories$719 $758 
v3.25.1
Goodwill and Other Intangible Assets (Tables)
6 Months Ended
Mar. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Changes in Carrying Amount of Goodwill
The changes in the carrying amount of goodwill are as follows:

(in millions)AmericasEMEAAsiaTotal
Balance at September 30, 2024$606 $341 $1,217 $2,164 
Impairment— (333)— (333)
Currency translation(2)(8)(37)(47)
Balance at March 31, 2025
$604 $— $1,180 $1,784 
Schedule of Intangible Assets
Adient's intangible assets, primarily from business acquisitions valued based on independent appraisals, consisted of:

 March 31, 2025September 30, 2024
(in millions)Gross
Carrying
Amount
Accumulated
Amortization
NetGross
Carrying
Amount
Accumulated
Amortization
Net
Intangible assets
Patented technology$79 $(41)$38 $81 $(39)$42 
Customer relationships531 (244)287 563 (246)317 
Trademarks and other14 (3)11 25 (13)12 
Total intangible assets$624 $(288)$336 $669 $(298)$371 
v3.25.1
Product Warranties (Tables)
6 Months Ended
Mar. 31, 2025
Product Warranties Disclosures [Abstract]  
Schedule of Product Warranty Liability
The changes in Adient's total product warranty liability are as follows:
Six Months Ended
March 31,
(in millions)20252024
Balance at beginning of period$22 $21 
Accruals for warranties issued during the period
Settlements/adjustments made (in cash or in kind) during the period(5)(4)
Balance at end of period$20 $21 
v3.25.1
Leases (Tables)
6 Months Ended
Mar. 31, 2025
Leases [Abstract]  
Schedule of Lease Cost
The components of lease costs included in the consolidated statements of income (loss) for the three and six months ended March 31, 2025 and 2024 were as follows:

Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)2025202420252024
Operating lease cost$27 $27 $54 $54 
Short-term lease cost14 15 
Total lease cost$34 $35 $68 $69 
Supplemental cash flow information related to leases is as follows:

Six Months Ended
March 31,
(in millions)20252024
Right-of-use assets obtained in exchange for lease obligations:
Operating leases (non-cash activity)$40 $51 
Operating cash flows:
Cash paid for amounts included in the measurement of lease liabilities$53 $55 
Schedule of Operating Lease Right of Use Assets and Operating Lease Liabilities
Operating lease right-of-use assets and lease liabilities included in the consolidated statements of financial position were as follows:

(in millions)March 31, 2025September 30, 2024
Operating leases:
Operating lease right-of-use assetsOther noncurrent assets$240$248
Operating lease liabilities - currentOther current liabilities$80$78
Operating lease liabilities - noncurrentOther noncurrent liabilities158168
$238$246
Weighted average remaining lease term:
Operating leases5 years5 years
Weighted average discount rate:
Operating leases6.1 %6.2 %
Schedule of Operating Lease Liabilities and Minimum Payments
Maturities of operating lease liabilities and minimum payments for operating leases having initial or remaining non-cancelable terms in excess of one year as of March 31, 2025 are as follows:

Operating leases
Fiscal years (in millions)March 31, 2025
2025 (excluding the six months ended March 31, 2025)
$49 
202675 
202754 
202834 
202918 
Thereafter43 
Total lease payments273 
Less: imputed interest(35)
Present value of lease liabilities$238 
v3.25.1
Debt and Financing Arrangements (Tables)
6 Months Ended
Mar. 31, 2025
Debt Disclosure [Abstract]  
Schedule of Debt
Long-term and short-term debt consisted of the following:

(in millions)March 31, 2025September 30, 2024
Long-term debt:
8.25% Notes due 2031
$500 $500 
7.00% Secured Notes due 2028
500 500 
Term Loan B due in 2031629 632 
4.875% Notes due in 2026
— 795 
7.50% Notes due in 2033
795 — 
Other bank borrowings and finance lease obligations
Less: debt issuance costs(35)(28)
Gross long-term debt2,394 2,404 
Less: current portion
Net long-term debt$2,386 $2,396 
Short-term debt:
Other bank borrowings$$
Total short-term debt$$
Schedule of Net Financing Charges
Adient's net financing charges in the consolidated statements of income (loss) contained the following components:

Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)2025202420252024
Interest expense, net of capitalized interest costs$48 $46 $95 $94 
Banking fees and debt issuance cost amortization11 
Interest income(6)(6)(13)(15)
Net foreign exchange(1)— 
Net financing charges$48 $47 $93 $91 
v3.25.1
Derivative Instruments and Hedging Activities (Tables)
6 Months Ended
Mar. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Fair Values of Derivative Instruments and Other Amounts
The following table presents the location and fair values of derivative instruments and other amounts used in hedging activities included in Adient's consolidated statements of financial position:

 Derivatives and Hedging
Activities Designated as
Hedging Instruments
under ASC 815
Derivatives and Hedging
Activities Not Designated as
Hedging Instruments
under ASC 815
(in millions)March 31, 2025September 30, 2024March 31, 2025September 30, 2024
Other current assets
Foreign currency exchange derivatives$10 $$$
Other noncurrent assets
Foreign currency exchange derivatives— 
Total assets$11 $10 $$
Other current liabilities
Foreign currency exchange derivatives$21 $32 $— $— 
Other noncurrent liabilities
Foreign currency exchange derivatives— — 
Total liabilities$23 $41 $— $— 
Schedule of Gross and Net Amounts of Derivative Instruments and Other Amounts
The gross and net amounts of derivative instruments and other amounts used in hedging activities are as follows:

AssetsLiabilities
(in millions)March 31, 2025September 30, 2024March 31, 2025September 30, 2024
Gross amount recognized$12 $18 $23 $41 
Gross amount eligible for offsetting(9)(9)(9)(9)
Net amount$$$14 $32 
Schedule of Effective Portion of Pretax Gains (Losses)
The following table presents the effective portion of pretax gains (losses) recorded in other comprehensive income related to cash flow hedges:

Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)2025202420252024
Foreign currency exchange derivatives$13 $12 $(1)$38 
The following table presents the location and amount of the effective portion of pretax gains (losses) on cash flow hedges reclassified from AOCI into Adient's consolidated statements of income (loss):
(in millions)Three Months Ended
March 31,
Six Months Ended
March 31,
2025202420252024
Foreign currency exchange derivativesCost of sales$(9)$18 $(17)$33 
The following table presents the location and amount of pretax gains (losses) on fair value hedge activity in Adient's consolidated statements of income (loss):
(in millions)Three Months Ended
March 31,
Six Months Ended
March 31,
2025202420252024
Foreign currency exchange derivativesNet financing charges$— $(3)$— $
The following table presents the location and amount of pretax gains (losses) on derivatives not designated as hedging instruments recognized in Adient's consolidated statements of income (loss):

(in millions)Three Months Ended
March 31,
Six Months Ended
March 31,
2025202420252024
Foreign currency exchange derivativesCost of sales$$(2)$— $(1)
Foreign currency exchange derivativesNet financing charges(1)(8)(14)
Total$$(10)$(14)$— 
v3.25.1
Fair Value Measurements (Tables)
6 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of the Fair Value Hierarchy for Assets and Liabilities
The following tables present Adient's fair value hierarchy for those assets and liabilities measured at fair value:

 Fair Value Measurements Using:
(in millions)
Total as of
March 31, 2025
Quoted Prices
in Active
Markets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Other current assets
Foreign currency exchange derivatives$11 $— $11 $— 
Other noncurrent assets
Foreign currency exchange derivatives— — 
Total assets$12 $— $12 $— 
Other current liabilities
Foreign currency exchange derivatives$21 — $21 — 
Other noncurrent liabilities
Foreign currency exchange derivatives— — 
Total liabilities$23 $— $23 $— 

Fair Value Measurements Using:
(in millions)
Total as of
September 30, 2024
Quoted Prices
in Active
Markets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Other current assets
Foreign currency exchange derivatives$15 $— $15 $— 
Other noncurrent assets
Foreign currency exchange derivatives— — 
Total assets$18 $— $18 $— 
Other current liabilities
Foreign currency exchange derivatives$32 $— $32 $— 
Other noncurrent liabilities
Foreign currency exchange derivatives— — 
Total liabilities$41 $— $41 $— 
v3.25.1
Equity and Noncontrolling Interests (Tables)
6 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Schedule of Stockholders Equity
For the three months ended March 31, 2025:

(in millions)Ordinary SharesAdditional Paid-in CapitalRetained Earnings
(Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)Shareholders' Equity Attributable
 to Adient
Shareholders' Equity Attributable to Noncontrolling InterestsTotal Equity
Balance at December 31, 2024$ $3,682 $(885)$(920)$1,877 $284 $2,161 
Net income (loss)— — (335)— (335)14 (321)
Foreign currency translation adjustments— — — 89 89 93 
Realized and unrealized gains on derivatives— — — 17 17 — 17 
Dividends attributable to noncontrolling interests— — — —  (5)(5)
Share based compensation and other— — — 4 — 4 
Balance at March 31, 2025
$ $3,686 $(1,220)$(814)$1,652 $297 $1,949 

For the six months ended March 31, 2025:

(in millions)Ordinary SharesAdditional Paid-in CapitalRetained Earnings
(Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)Shareholders' Equity Attributable
 to Adient
Shareholders' Equity Attributable to Noncontrolling InterestsTotal Equity
Balance at September 30, 2024$ $3,712 $(885)$(693)$2,134 $309 $2,443 
Net income (loss)— — (335)— (335)29 (306)
Foreign currency translation adjustments— — — (128)(128)(7)(135)
Realized and unrealized gains on derivatives— — — 9 — 9 
Dividends attributable to noncontrolling interests— — — —  (15)(15)
Purchase of noncontrolling interest (1)
— (7)— (2)(9)(19)(28)
Repurchases of common stock— (25)— — (25)— (25)
Share based compensation and other— — — 6 — 6 
Balance at March 31, 2025
$ $3,686 $(1,220)$(814)$1,652 $297 $1,949 

(1) Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for additional information.
For the three months ended March 31, 2024:

(in millions)Ordinary SharesAdditional Paid-in CapitalRetained Earnings
(Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)Shareholders' Equity Attributable
 to Adient
Shareholders' Equity Attributable to Noncontrolling InterestsTotal Equity
Balance at December 31, 2023$ $3,872 $(883)$(704)$2,285 $331 $2,616 
Net income (loss)— — (70)— (70)14 (56)
Foreign currency translation adjustments— — — (92)(92)(4)(96)
Realized and unrealized losses on derivatives— — — (6)(6)— (6)
Dividends attributable to noncontrolling interests— — — —  (14)(14)
Repurchases of common stock— (50)— — (50)— (50)
Share based compensation and other— — — 8 — 8 
Balance at March 31, 2024
$ $3,830 $(953)$(802)$2,075 $327 $2,402 

For the six months ended March 31, 2024:

(in millions)Ordinary SharesAdditional Paid-in CapitalRetained Earnings
(Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)Shareholders' Equity Attributable
 to Adient
Shareholders' Equity Attributable to Noncontrolling InterestsTotal Equity
Balance at September 30, 2023$ $3,973 $(903)$(842)$2,228 $318 $2,546 
Net income (loss)— — (50)— (50)26 (24)
Foreign currency translation adjustments— — — 37 37 38 
Realized and unrealized gains on derivatives— — — 3 — 3 
Dividends attributable to noncontrolling interests— — — —  (18)(18)
Repurchases of common stock— (150)— — (150)— (150)
Share based compensation and other— — — 7 — 7 
Balance at March 31, 2024
$ $3,830 $(953)$(802)$2,075 $327 $2,402 
Schedule of AOCI
The following table presents changes in AOCI attributable to Adient:

Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)2025202420252024
Foreign currency translation adjustments
Balance at beginning of period$(892)$(725)$(673)$(854)
Aggregate adjustment for the period, net of tax89 (92)(130)37 
Balance at end of period (1)
$(803)$(817)$(803)$(817)
Realized and unrealized gains (losses) on derivatives
Balance at beginning of period$(27)$22 $(19)$13 
Current period changes in fair value, net of tax11 (3)29 
Reclassification to income, net of tax(14)12 (26)
Balance at end of period$(10)$16 $(10)$16 
Pension and postretirement plans
Balance at beginning of period$(1)$(1)$(1)$(1)
Balance at end of period$(1)$(1)$(1)$(1)
Accumulated other comprehensive loss, end of period$(814)$(802)$(814)$(802)
(1) Foreign currency translation adjustments as of March 31, 2025 and 2024 include gains on designated net investment hedge instruments of $0 million and $1 million, respectively. During the next twelve months, no gains or losses are expected to be reclassified from AOCI into Adient's consolidated statements of income (loss).
Schedule of Changes in Redeemable Noncontrolling Interest The following table presents changes in the redeemable noncontrolling interests:
Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)2025202420252024
Beginning balance$62 $57 $91 $57 
Net income (1)
18 20 
Dividends— — (31)(21)
Foreign currency translation adjustments(6)(7)
Ending balance$71 $58 $71 $58 

(1) During the six months ended March 31, 2024, a $5 million adjustment was recorded to increase income attributable to noncontrolling interest related to fiscal 2023.
v3.25.1
Retirement Plans (Tables)
6 Months Ended
Mar. 31, 2025
Retirement Benefits [Abstract]  
Schedule of Net Periodic Benefit Cost The following table contains the components of net periodic benefit cost:
Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)2025202420252024
Service cost$$$$
Interest cost10 
Expected return on plan assets(4)(3)(7)(6)
Net periodic benefit cost$$$$
v3.25.1
Restructuring and Impairment Costs (Tables)
6 Months Ended
Mar. 31, 2024
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Reserve The following tables summarize the changes in Adient's restructuring reserve.
For the three months ended March 31, 2025:

(in millions)Employee Severance and Termination BenefitsCurrency
Translation
Total
Balance at December 31, 2024$165 $(11)$154 
2025 Plan charges24 — 24 
Utilized - cash(28)— (28)
Noncash and other adjustments(6)
Balance at March 31, 2025
$155 $(3)$152 
Current restructuring reserve - other current liabilities$91 
Noncurrent restructuring reserve - other noncurrent liabilities61 
Balance at March 31, 2025$152 

For the six months ended March 31, 2025:

(in millions)Employee Severance and Termination BenefitsCurrency
Translation
Total
Balance at September 30, 2024$181 $$182 
2025 Plan charges33 — 33 
Utilized - cash(57)— (57)
Noncash and other adjustments(2)(4)(6)
Balance at March 31, 2025
$155 $(3)$152 
For the three months ended March 31, 2024:

(in millions)Employee Severance and Termination BenefitsCurrency
Translation
Total
Balance at December 31, 2023$58 $(4)$54 
2024 Plan charges127 — 127 
Utilized - cash(8)— (8)
Noncash and other adjustments(2)(2)(4)
Balance at March 31, 2024$175 $(6)$169 
Current restructuring reserve - other current liabilities$64 
Noncurrent restructuring reserve - other noncurrent liabilities105 
Balance at March 31, 2024$169 

For the six months ended March 31, 2024:

(in millions)Employee Severance and Termination BenefitsCurrency
Translation
Total
Balance at September 30, 2023$56 $(5)$51 
2024 Plan charges138 — 138 
Utilized - cash(17)— (17)
Noncash and other adjustments(2)(1)(3)
Balance at March 31, 2024$175 $(6)$169 
v3.25.1
Segment Information (Tables)
6 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Schedule of Financial Information for Reportable Segments
The following table summarizes net sales and adjusted EBITDA by reportable segment for the three and six months ended March 31, 2025 and 2024:

(in millions)AmericasEMEAAsiaCorporate/EliminationsConsolidated
Three months ended March 31, 2025
Net sales$1,699 $1,231 $707 $(26)$3,611 
Adjusted EBITDA$94 $50 $110 $(21)$233 
Six months ended March 31, 2025
Net sales$3,310 $2,360 $1,479 $(43)$7,106 
Adjusted EBITDA$179 $72 $221 $(43)$429 
Three months ended March 31, 2024
Net sales$1,660 $1,370 $742 $(22)$3,750 
Adjusted EBITDA$80 $57 $112 $(22)$227 
Six months ended March 31, 2024
Net sales$3,307 $2,638 $1,512 $(47)$7,410 
Adjusted EBITDA$160 $102 $226 $(45)$443 
The following is a reconciliation of Adient's reportable segments' adjusted EBITDA to income (loss) before income taxes:

Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)2025202420252024
Adjusted EBITDA
Americas$94 $80 $179 $160 
EMEA50 57 72 102 
Asia110 112 221 226 
Subtotal254 249 472 488 
Corporate-related costs (1)
(21)(22)(43)(45)
Restructuring and impairment costs (2)
(351)(125)(374)(136)
Purchase accounting amortization (3)
(12)(13)(23)(24)
Restructuring related charges (4)
(5)(2)(6)
Gain (loss) on disposal transactions (5)
— — (8)
Depreciation
(67)(70)(136)(142)
Equity based compensation (6)
(5)(10)(10)(23)
Other items (7)
(9)(7)
Earnings before interest and income taxes(216)(123)119 
Net financing charges(48)(47)(93)(91)
Other pension expense(1)(2)(2)(4)
Income (loss) before income taxes$(265)$(41)$(218)$24 

Notes:

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.
(2) Reflects restructuring charges for costs that are probable and reasonably estimable and non-recurring asset impairments. The three months ended March 31, 2025 reflects restructuring charges of $18 million, and a non-recurring, non-cash goodwill impairment charge of $333 million in the EMEA reporting unit. The six months ended March 31, 2025 reflects restructuring charges of $31 million, a non-recurring, non-cash goodwill impairment charge of $333 million in the EMEA reporting unit, and an impairment charge of $10 million related to Adient’s investment in Adient Aerospace. Refer to Note 5, "Goodwill and Other Intangible Assets" and Note 13, "Restructuring and Impairment Costs" of the notes to the consolidated financial statements for additional information.
(3) Reflects amortization of intangible assets including those related to partially-owned affiliates recorded within equity income.
(4) Reflects restructuring-related charges for costs that are recorded as incurred or as earned and other non-recurring impacts that are directly attributable to restructuring activities. The six months ended March 31, 2025 and 2024 include a $5 million and a $10 million gain on sale of restructured facilities, respectively.
(5) The six months ended March 31, 2025 reflects a $4 million gain on sale of Adient's partially-owned investment in Setex. The six months ended March 31, 2024 reflects an $8 million loss on sale of 51% of Adient's interest in LFADNT. Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for additional information.
(6) During the six months ended March 31, 2024, a $5 million adjustment was recorded to increase equity-based compensation expense related to a retired executive's equity awards that should have been recognized in periods prior to fiscal 2023.
(7) The three months ended March 31, 2025 includes $8 million of third-party consulting costs associated with strategic planning and a $1 million non-recurring loss at affiliates. The six months ended March 31, 2025 includes $8 million of third-party consulting costs associated with strategic planning and a $1 million non-recurring loss at affiliates, partially offset by a
$2 million gain on a non-recurring contract related settlement. The three months ended March 31, 2024 reflects $1 million of indirect tax recoveries in Brazil. The six months ended March 31, 2024 includes a $3 million non-recurring gain on a contract related settlement and $1 million of indirect tax recoveries in Brazil, partially offset by $2 million one-time divestiture related tax impact at an affiliate.
Schedule of Disaggregation of Revenue by Geographical Market
Revenue by geographic area is as follows:

Net Sales
 Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)2025202420252024
Americas
United States$1,565 $1,491 $3,010 $2,913 
Mexico606 628 1,214 1,260 
Other Americas70 61 145 147 
Regional elimination(542)(520)(1,059)(1,013)
1,699 1,660 3,310 3,307 
EMEA
Germany242 254 451478 
Poland214 249 415 498 
Czech Republic180 220 356 415 
Spain179 206 360 386 
Sweden142 157 281 309 
Other EMEA579 658 1,089 1,275 
Regional elimination(305)(374)(592)(723)
1,231 1,370 2,360 2,638 
Asia
China286 336 621 710 
Thailand131 126 254 248 
Korea126 128 273 250 
Japan106 86 213 179 
Other Asia74 78 152 149 
Regional elimination(16)(12)(34)(24)
707 742 1,479 1,512 
Inter-segment elimination(26)(22)(43)(47)
Total$3,611 $3,750 $7,106 $7,410 
v3.25.1
Nonconsolidated Partially-Owned Affiliates (Tables)
6 Months Ended
Mar. 31, 2025
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Operating Information of Nonconsolidated Partially-Owned Affiliates Operating information for nonconsolidated partially-owned affiliates is as follows:
Six Months Ended
March 31,
(in millions)20252024
Income statement data:
Net sales$1,819 $1,938 
Gross profit$159 $204 
Net income$80 $89 
Net income attributable to the entity$78 $88 
v3.25.1
Related Party Transactions (Tables)
6 Months Ended
Mar. 31, 2025
Related Party Transactions [Abstract]  
Schedule of Related Party Transactions
The following table sets forth the net sales to and purchases from related parties included in the consolidated statements of income (loss):

Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)2025202420252024
Net sales to related partiesNet sales$28 $65 $84 $131 
Purchases from related partiesCost of sales76 110 159 213 
The following table sets forth the amount of accounts receivable due from and payable to related parties in the consolidated statements of financial position:

(in millions)March 31, 2025September 30, 2024
Receivables from related partiesAccounts receivable$12 $28 
Payables to related partiesAccounts payable/other current liabilities21 114 
v3.25.1
Organization and Summary of Significant Accounting Policies - Narrative (Details) - entity
Mar. 31, 2025
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Number of VIE entities 2 2
v3.25.1
Organization and Summary of Significant Accounting Policies - Schedule of Carrying Amounts and Classifications of Assets and Liabilities for Consolidated VIEs (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Sep. 30, 2024
Variable Interest Entity [Line Items]    
Current assets $ 3,892 $ 4,086
Total assets 8,589 9,351
Current liabilities 3,509 3,678
Noncurrent liabilities 3,060 3,139
VIEs    
Variable Interest Entity [Line Items]    
Current assets 309 285
Noncurrent assets 95 98
Total assets 404 383
Current liabilities 267 241
Noncurrent liabilities 11 12
Total liabilities $ 278 $ 253
v3.25.1
Organization and Summary of Significant Accounting Policies - Schedule of Computation of Basic and Diluted Earnings (Loss) Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Income available to shareholders        
Net loss attributable to Adient $ (335) $ (70) $ (335) $ (50)
Weighted average shares outstanding        
Basic weighted average shares outstanding (in shares) 84.0 90.5 84.2 91.7
Stock options, unvested restricted stock and unvested performance share awards (in shares) 0.0 0.0 0.0 0.0
Diluted weight average shares outstanding (in shares) 84.0 90.5 84.2 91.7
Loss per share:        
Basic (in usd per share) $ (3.99) $ (0.77) $ (3.98) $ (0.55)
Diluted (in usd per share) $ (3.99) $ (0.77) $ (3.98) $ (0.55)
v3.25.1
Revenue Recognition (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2025
Sep. 30, 2024
Disaggregation of Revenue [Line Items]      
Revenues related to prior year sales, percent 2.00%    
Contract with customer, asset noncurrent $ 160 $ 160 $ 155
Minimum      
Disaggregation of Revenue [Line Items]      
Term of the program   3 years  
Maximum      
Disaggregation of Revenue [Line Items]      
Term of the program   7 years  
v3.25.1
Acquisitions and Divestitures (Details)
¥ in Millions, $ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Mar. 31, 2025
USD ($)
Mar. 31, 2024
USD ($)
Dec. 31, 2023
CNY (¥)
Disposed of By Sale | Adient (Langfang) Seating Co., Ltd          
Business Acquisition [Line Items]          
Subsidiary, ownership percentage disposed   51.00%   51.00% 51.00%
Consideration for disposal group   $ 6     ¥ 44
Deconsolidated cash   9      
Loss on disposal   8   $ 8  
Disposed of By Sale | Adient (Langfang) Seating Co., Ltd | Asia          
Business Acquisition [Line Items]          
Goodwill   $ 5      
Assets Held For Sale | Adient (Langfang) Seating Co., Ltd          
Business Acquisition [Line Items]          
Subsidiary, ownership percentage disposed   100.00%     100.00%
Setex, Inc.          
Business Acquisition [Line Items]          
Proceeds from sale of investments $ 27        
Gain on sale 4   $ 4    
Technotrim, Inc.          
Business Acquisition [Line Items]          
Net purchase consideration $ 28        
v3.25.1
Inventories (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Sep. 30, 2024
Inventory Disclosure [Abstract]    
Raw materials and supplies $ 550 $ 582
Work-in-process 29 29
Finished goods 140 147
Inventories $ 719 $ 758
v3.25.1
Goodwill and Other Intangible Assets - Schedule of Changes in Carrying Amount of Goodwill (Details)
$ in Millions
6 Months Ended
Mar. 31, 2025
USD ($)
Goodwill [Roll Forward]  
Beginning balance $ 2,164
Impairment (333)
Currency translation (47)
Ending balance 1,784
Americas  
Goodwill [Roll Forward]  
Beginning balance 606
Impairment 0
Currency translation (2)
Ending balance 604
EMEA  
Goodwill [Roll Forward]  
Beginning balance 341
Impairment (333)
Currency translation (8)
Ending balance 0
Asia  
Goodwill [Roll Forward]  
Beginning balance 1,217
Impairment 0
Currency translation (37)
Ending balance $ 1,180
v3.25.1
Goodwill and Other Intangible Assets - Narrative (Details)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
USD ($)
Mar. 31, 2025
USD ($)
segment
Mar. 31, 2024
USD ($)
Sep. 30, 2024
USD ($)
Finite-Lived Intangible Assets [Line Items]        
Impairment   $ 333    
Goodwill $ 1,784 1,784   $ 2,164
Amortization of intangibles   $ 23 $ 23  
Number of reportable segments | segment   3    
EMEA        
Finite-Lived Intangible Assets [Line Items]        
Impairment   $ 333    
Goodwill $ 0 $ 0   $ 341
Minimum | Significant Unobservable Inputs (Level 3) | Measurement Input, Cap Rate | Valuation, Income Approach        
Finite-Lived Intangible Assets [Line Items]        
Reporting unit, measurement input 16.50%      
Maximum | Significant Unobservable Inputs (Level 3) | Measurement Input, Cap Rate | Valuation, Income Approach        
Finite-Lived Intangible Assets [Line Items]        
Reporting unit, measurement input 21.00%      
v3.25.1
Goodwill and Other Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Sep. 30, 2024
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 624 $ 669
Accumulated Amortization (288) (298)
Net 336 371
Patented technology    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 79 81
Accumulated Amortization (41) (39)
Net 38 42
Customer relationships    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 531 563
Accumulated Amortization (244) (246)
Net 287 317
Trademarks and other    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 14 25
Accumulated Amortization (3) (13)
Net $ 11 $ 12
v3.25.1
Product Warranties (Details) - USD ($)
$ in Millions
6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Movement in Standard Product Warranty Accrual [Roll Forward]    
Balance at beginning of period $ 22 $ 21
Accruals for warranties issued during the period 3 4
Settlements/adjustments made (in cash or in kind) during the period (5) (4)
Balance at end of period $ 20 $ 21
v3.25.1
Leases - Schedule of Lease Cost (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Leases [Abstract]        
Operating lease cost $ 27 $ 27 $ 54 $ 54
Short-term lease cost 7 8 14 15
Total lease cost $ 34 $ 35 $ 68 $ 69
v3.25.1
Leases - Schedule of Operating Lease Right of Use Assets and Operating Lease Liabilities (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Sep. 30, 2024
Leases [Abstract]    
Operating lease right-of-use assets $ 240 $ 248
Operating lease liabilities - current 80 78
Operating lease liabilities - noncurrent 158 168
Present value of lease liabilities $ 238 $ 246
Weighted average remaining lease term:    
Operating leases 5 years 5 years
Weighted average discount rate:    
Operating leases 6.10% 6.20%
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Other noncurrent assets Other noncurrent assets
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Other current liabilities Other current liabilities
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Noncurrent Other Liabilities, Noncurrent
v3.25.1
Leases - Schedule of Operating Lease Liabilities and Minimum Payments (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Sep. 30, 2024
Operating leases    
2025 (excluding the six months ended March 31, 2025) $ 49  
2026 75  
2027 54  
2028 34  
2029 18  
Thereafter 43  
Total lease payments 273  
Less: imputed interest (35)  
Present value of lease liabilities $ 238 $ 246
v3.25.1
Leases - Schedule of Supplemental Cash Flow Information (Details) - USD ($)
$ in Millions
6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Right-of-use assets obtained in exchange for lease obligations:    
Operating leases (non-cash activity) $ 40 $ 51
Operating cash flows:    
Cash paid for amounts included in the measurement of lease liabilities $ 53 $ 55
v3.25.1
Debt and Financing Arrangements - Schedule of Debt (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Feb. 28, 2025
Sep. 30, 2024
Long-term debt:      
Less: debt issuance costs $ (35)   $ (28)
Gross long-term debt 2,394   2,404
Less: current portion 8   8
Net long-term debt 2,386   2,396
Short-term debt:      
Other bank borrowings 2   1
Total short-term debt 2   1
Term Loan B due in 2031      
Long-term debt:      
Long-term debt, gross $ 629   632
Unsecured debt | 8.25% Notes due 2031      
Long-term debt:      
Interest rate 8.25%    
Long-term debt, gross $ 500   $ 500
Unsecured debt | 4.875% Notes due in 2026      
Long-term debt:      
Interest rate 4.875%   4.875%
Long-term debt, gross $ 0   $ 795
Unsecured debt | 7.50% Notes due in 2033      
Long-term debt:      
Interest rate   7.50%  
Long-term debt, gross 795   0
Unsecured debt | Other bank borrowings and finance lease obligations      
Long-term debt:      
Long-term debt, gross $ 5   5
Term Loan | 7.00% Secured Notes due 2028      
Long-term debt:      
Interest rate 7.00%    
Long-term debt, gross $ 500   $ 500
v3.25.1
Debt and Financing Arrangements - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2025
Feb. 28, 2025
Mar. 31, 2025
Dec. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Sep. 30, 2024
Sep. 30, 2023
Oct. 01, 2023
Debt Instrument [Line Items]                  
Total interest paid         $ 84,000,000 $ 97,000,000      
Proceeds from sale and collection of receivables $ 170,000,000                
Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration] Accounts Payable, Current   Accounts Payable, Current   Accounts Payable, Current   Accounts Payable, Current    
Supplier finance program, obligation, current $ 91,000,000   $ 91,000,000   $ 91,000,000   $ 76,000,000    
7.000 % Senior Secured Notes Due 2028 | Senior notes                  
Debt Instrument [Line Items]                  
Face amount of debt (up to) $ 500,000,000   $ 500,000,000   $ 500,000,000        
Interest rate 7.00%   7.00%   7.00%        
8.250% Senior unsecured Notes Due 2031 | Unsecured debt                  
Debt Instrument [Line Items]                  
Face amount of debt (up to) $ 500,000,000   $ 500,000,000   $ 500,000,000        
Interest rate 8.25%   8.25%   8.25%        
4.875% Notes due in 2026 | Unsecured debt                  
Debt Instrument [Line Items]                  
Face amount of debt (up to) $ 795,000,000   $ 795,000,000   $ 795,000,000   $ 795,000,000    
Interest rate 4.875%   4.875%   4.875%   4.875%    
Repayment of debt     $ 2,000,000   $ 2,000,000        
7.50% Notes due in 2033 | Unsecured debt                  
Debt Instrument [Line Items]                  
Face amount of debt (up to)   $ 795,000,000              
Interest rate   7.50%              
Proceeds from debt   $ 783,000,000              
Minimum                  
Debt Instrument [Line Items]                  
Supplier finance program, payment period                 45 days
Maximum                  
Debt Instrument [Line Items]                  
Supplier finance program, payment period                 120 days
Revolving Credit Facility                  
Debt Instrument [Line Items]                  
Maximum borrowing capacity $ 1,250,000,000   1,250,000,000   1,250,000,000        
Credit facility expansion         250,000,000        
Remaining borrowing capacity 843,000,000   843,000,000   $ 843,000,000        
Revolving Credit Facility | Minimum                  
Debt Instrument [Line Items]                  
Commitment fee on unused portion of commitments         0.25%        
Basis spread         1.50%        
Revolving Credit Facility | Maximum                  
Debt Instrument [Line Items]                  
Commitment fee on unused portion of commitments         0.375%        
Basis spread         2.00%        
Revolving Credit Facility | North American Subfacility                  
Debt Instrument [Line Items]                  
Maximum borrowing capacity 950,000,000   950,000,000   $ 950,000,000        
Revolving Credit Facility | European Subfacility                  
Debt Instrument [Line Items]                  
Maximum borrowing capacity 300,000,000   300,000,000   300,000,000        
Letter of Credit                  
Debt Instrument [Line Items]                  
Maximum borrowing capacity 150,000,000   150,000,000   150,000,000        
Remaining borrowing capacity 8,000,000   8,000,000   8,000,000        
Term Loan | Term Loan B due in 2031                  
Debt Instrument [Line Items]                  
Debt instrument, modification cost       $ 1,000,000     $ 5,000,000    
Debt issuance costs, gross             $ 4,000,000    
Term Loan | Term Loan B due in 2031                  
Debt Instrument [Line Items]                  
Basis spread       2.25%     2.75% 3.25%  
Face amount of debt (up to) $ 629,000,000   $ 629,000,000   $ 629,000,000   $ 632,000,000    
Debt instrument, period payment, percentage     1.00%            
First lien secured net leverage ratio       1.75          
Deferred financing costs write off           $ 2,000,000      
Term Loan | Incremental Term Loan                  
Debt Instrument [Line Items]                  
Face amount of debt (up to)       $ 750,000,000          
Term Loan | 7.50% Notes due in 2033                  
Debt Instrument [Line Items]                  
Debt issuance costs, gross             $ 12,000,000    
v3.25.1
Debt and Financing Arrangements - Schedule of Net Financing Charges (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Debt Disclosure [Abstract]        
Interest expense, net of capitalized interest costs $ 48 $ 46 $ 95 $ 94
Banking fees and debt issuance cost amortization 7 5 11 9
Interest income (6) (6) (13) (15)
Net foreign exchange (1) 2 0 3
Net financing charges $ 48 $ 47 $ 93 $ 91
v3.25.1
Derivative Instruments and Hedging Activities - Narrative (Details)
€ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
USD ($)
Mar. 31, 2024
USD ($)
Mar. 31, 2025
USD ($)
Mar. 31, 2024
USD ($)
Mar. 31, 2025
EUR (€)
Sep. 30, 2024
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2024
CNY (¥)
Mar. 31, 2024
CNY (¥)
Derivative [Line Items]                  
Percentage of foreign exchange rate exposure hedged, minimum 70.00%   70.00%   70.00%        
Percentage of foreign exchange rate exposure hedged, maximum 90.00%   90.00%   90.00%        
Cash collateral received $ 0   $ 0     $ 0      
Cash collateral pledged 0   0     $ 0      
Pre tax loss to be reclassified within next 12 months 11,000,000   11,000,000            
Cash Flow Hedging                  
Derivative [Line Items]                  
Ineffectiveness recognized from cash flow hedges 0 $ 0 0 $ 0          
Foreign currency exchange derivatives | Net Investment Hedging                  
Derivative [Line Items]                  
Effective portion of pretax gains (loss) related to net investment hedges $ (1,000,000) 1,000,000 3,000,000 (1,000,000)          
Gains (losses) reclassified into income for net investment hedges     $ 0 0          
China | Cross-currency interest rate swaps | Net Investment Hedging                  
Derivative [Line Items]                  
Notional amount of derivative asset   $ 96,000,000   $ 96,000,000     $ 78,000,000 ¥ 570,000,000 ¥ 685,000,000
7.50% Notes due in 2033 | Unsecured debt                  
Derivative [Line Items]                  
Long-term debt, gross | €         € 123        
7.50% Notes due in 2033 | Unsecured debt | Derivatives and Hedging Activities Designated as Hedging Instruments under ASC 815                  
Derivative [Line Items]                  
Interest rate 3.50%   3.50%   3.50%        
v3.25.1
Derivative Instruments and Hedging Activities - Schedule of Fair Values of Derivative Instruments and Other Amounts (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Sep. 30, 2024
Derivatives, Fair Value [Line Items]    
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration] Other current assets Other current assets
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other noncurrent assets Other noncurrent assets
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration] Other current liabilities Other current liabilities
Derivatives and Hedging Activities Designated as Hedging Instruments under ASC 815    
Derivatives, Fair Value [Line Items]    
Total assets $ 11 $ 10
Total liabilities 23 41
Derivatives and Hedging Activities Designated as Hedging Instruments under ASC 815 | Foreign currency exchange derivatives    
Derivatives, Fair Value [Line Items]    
Other current assets 10 9
Other noncurrent assets 1 1
Other current liabilities 21 32
Derivative liability, noncurrent 2 9
Derivatives and Hedging Activities Not Designated as Hedging Instruments under ASC 815    
Derivatives, Fair Value [Line Items]    
Total assets 1 8
Total liabilities 0 0
Derivatives and Hedging Activities Not Designated as Hedging Instruments under ASC 815 | Foreign currency exchange derivatives    
Derivatives, Fair Value [Line Items]    
Other current assets 1 6
Other noncurrent assets 0 2
Other current liabilities 0 0
Derivative liability, noncurrent $ 0 $ 0
v3.25.1
Derivative Instruments and Hedging Activities - Schedule of Gross and Net Amounts of Derivative Instruments and Other Amounts (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Gross amount recognized, assets $ 12 $ 18
Gross amount eligible for offsetting, assets (9) (9)
Net amount, assets 3 9
Gross amount recognized, liabilities 23 41
Gross amount eligible for offsetting, liabilities (9) (9)
Net amount, liabilities $ 14 $ 32
v3.25.1
Derivative Instruments and Hedging Activities - Schedule of Effective Portion of Pretax Gains (Losses) (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Derivative Instruments, Gain (Loss) [Line Items]        
Total $ 2 $ (10) $ (14) $ 0
Foreign currency exchange derivatives | Cost of sales        
Derivative Instruments, Gain (Loss) [Line Items]        
Foreign currency exchange derivatives 3 (2) 0 (1)
Foreign currency exchange derivatives | Net financing charges        
Derivative Instruments, Gain (Loss) [Line Items]        
Foreign currency exchange derivatives (1) (8) (14) 1
Foreign currency exchange derivatives | Cash Flow Hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Foreign currency exchange derivatives 13 12 (1) 38
Foreign currency exchange derivatives | Cash Flow Hedging | Cost of sales        
Derivative Instruments, Gain (Loss) [Line Items]        
Foreign currency exchange derivatives (9) 18 (17) 33
Foreign currency exchange derivatives | Cash Flow Hedging | Net financing charges        
Derivative Instruments, Gain (Loss) [Line Items]        
Foreign currency exchange derivatives $ 0 $ (3) $ 0 $ 3
v3.25.1
Fair Value Measurements - Schedule of the Fair Value Hierarchy for Assets and Liabilities (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Sep. 30, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Asset, Statement of Financial Position [Extensible Enumeration]   Other current assets
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other noncurrent assets Other noncurrent assets
Total assets $ 12 $ 18
Total liabilities 23 41
Foreign currency exchange derivatives | Other current assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative asset 11 15
Foreign currency exchange derivatives | Other noncurrent assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative asset 1 3
Foreign currency exchange derivatives | Other current liabilities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liability 21 32
Foreign currency exchange derivatives | Other noncurrent liabilities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liability 2 9
Quoted Prices in Active Markets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 0 0
Total liabilities 0 0
Quoted Prices in Active Markets (Level 1) | Foreign currency exchange derivatives | Other current assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative asset 0 0
Quoted Prices in Active Markets (Level 1) | Foreign currency exchange derivatives | Other noncurrent assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative asset 0 0
Quoted Prices in Active Markets (Level 1) | Foreign currency exchange derivatives | Other current liabilities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liability 0 0
Quoted Prices in Active Markets (Level 1) | Foreign currency exchange derivatives | Other noncurrent liabilities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liability 0 0
Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 12 18
Total liabilities 23 41
Significant Other Observable Inputs (Level 2) | Foreign currency exchange derivatives | Other current assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative asset 11 15
Significant Other Observable Inputs (Level 2) | Foreign currency exchange derivatives | Other noncurrent assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative asset 1 3
Significant Other Observable Inputs (Level 2) | Foreign currency exchange derivatives | Other current liabilities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liability 21 32
Significant Other Observable Inputs (Level 2) | Foreign currency exchange derivatives | Other noncurrent liabilities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liability 2 9
Significant Unobservable Inputs (Level 3)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 0 0
Total liabilities 0 0
Significant Unobservable Inputs (Level 3) | Foreign currency exchange derivatives | Other current assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative asset 0 0
Significant Unobservable Inputs (Level 3) | Foreign currency exchange derivatives | Other noncurrent assets    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative asset 0 0
Significant Unobservable Inputs (Level 3) | Foreign currency exchange derivatives | Other current liabilities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liability 0 0
Significant Unobservable Inputs (Level 3) | Foreign currency exchange derivatives | Other noncurrent liabilities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liability $ 0 $ 0
v3.25.1
Fair Value Measurements - Narrative (Details) - USD ($)
$ in Billions
Mar. 31, 2025
Sep. 30, 2024
Fair Value, Inputs, Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair value of long-term debt $ 2.3 $ 2.4
v3.25.1
Equity and Noncontrolling Interests - Schedule of Stockholders Equity (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stockholders' equity, beginning balance $ 2,161 $ 2,616 $ 2,443 $ 2,546
Net income (loss) (321) (56) (306) (24)
Foreign currency translation adjustments 93 (96) (135) 38
Realized and unrealized losses on derivatives 17 (6) 9 3
Dividends attributable to noncontrolling interests (5) (14) (15) (18)
Purchase of noncontrolling interest     (28)  
Repurchases of common stock   (50) (25) (150)
Share based compensation and other 4 8 6 7
Stockholders' equity, ending balance 1,949 2,402 1,949 2,402
Shareholders' Equity Attributable to Adient        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stockholders' equity, beginning balance 1,877 2,285 2,134 2,228
Net income (loss) (335) (70) (335) (50)
Foreign currency translation adjustments 89 (92) (128) 37
Realized and unrealized losses on derivatives 17 (6) 9 3
Purchase of noncontrolling interest     (9)  
Repurchases of common stock   (50) (25) (150)
Share based compensation and other 4 8 6 7
Stockholders' equity, ending balance 1,652 2,075 1,652 2,075
Ordinary Shares        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stockholders' equity, beginning balance 0 0 0 0
Stockholders' equity, ending balance 0 0 0 0
Additional Paid-in Capital        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stockholders' equity, beginning balance 3,682 3,872 3,712 3,973
Purchase of noncontrolling interest     (7)  
Repurchases of common stock   (50) (25) (150)
Share based compensation and other 4 8 6 7
Stockholders' equity, ending balance 3,686 3,830 3,686 3,830
Retained Earnings (Accumulated Deficit)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stockholders' equity, beginning balance (885) (883) (885) (903)
Net income (loss) (335) (70) (335) (50)
Stockholders' equity, ending balance (1,220) (953) (1,220) (953)
Accumulated Other Comprehensive Income (Loss)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stockholders' equity, beginning balance (920) (704) (693) (842)
Foreign currency translation adjustments 89 (92) (128) 37
Realized and unrealized losses on derivatives 17 (6) 9 3
Purchase of noncontrolling interest     (2)  
Stockholders' equity, ending balance (814) (802) (814) (802)
Shareholders' Equity Attributable to Noncontrolling Interests        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stockholders' equity, beginning balance 284 331 309 318
Net income (loss) 14 14 29 26
Foreign currency translation adjustments 4 (4) (7) 1
Dividends attributable to noncontrolling interests (5) (14) (15) (18)
Purchase of noncontrolling interest     (19)  
Stockholders' equity, ending balance $ 297 $ 327 $ 297 $ 327
v3.25.1
Equity and Noncontrolling Interests - Schedule of AOCI (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Stockholders' equity, beginning balance $ 2,161 $ 2,616 $ 2,443 $ 2,546
Aggregate adjustment for the period, net of tax 111 (108) (133) 43
Stockholders' equity, ending balance 1,949 2,402 1,949 2,402
Accumulated Other Comprehensive Income (Loss)        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Stockholders' equity, beginning balance (920) (704) (693) (842)
Stockholders' equity, ending balance (814) (802) (814) (802)
Foreign currency translation adjustments        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Stockholders' equity, beginning balance (892) (725) (673) (854)
Aggregate adjustment for the period, net of tax 89 (92) (130) 37
Stockholders' equity, ending balance (803) (817) (803) (817)
Foreign currency translation adjustments | Net Investment Hedging        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Stockholders' equity, ending balance 0 1 0 1
Realized and unrealized gains (losses) on derivatives        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Stockholders' equity, beginning balance (27) 22 (19) 13
Current period changes in fair value, net of tax 11 8 (3) 29
Reclassification to income, net of tax 6 (14) 12 (26)
Stockholders' equity, ending balance (10) 16 (10) 16
Pension and postretirement plans        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Stockholders' equity, beginning balance (1) (1) (1) (1)
Stockholders' equity, ending balance $ (1) $ (1) $ (1) $ (1)
v3.25.1
Equity and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interest (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]        
Beginning balance     $ 309  
Dividends $ (5) $ (14) (15) $ (18)
Ending balance 297   297  
Restatement Adjustment        
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]        
Net income       5
Redeemable Noncontrolling Interest        
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]        
Beginning balance 62 57 91 57
Net income 8 7 18 20
Dividends 0 0 (31) (21)
Foreign currency translation adjustments 1 (6) (7) 2
Ending balance $ 71 $ 58 $ 71 $ 58
v3.25.1
Equity and Noncontrolling Interests - Narrative (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2024
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Sep. 30, 2024
Nov. 30, 2022
Equity [Abstract]            
Aggregate amount           $ 600,000,000
Stock repurchased and retired during period (in shares)     1,227,329   9,424,668  
Average repurchase price per share (in dollars per share)     $ 20.37   $ 29.18  
Stock repurchased and retired during period, value $ 25,000,000       $ 275,000,000  
Share repurchases   $ 150,000,000 $ 25,000,000 $ 150,000,000    
Stock repurchase program, remaining authorized repurchase amount     $ 235,000,000      
v3.25.1
Retirement Plans (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Retirement Benefits [Abstract]        
Service cost $ 2 $ 2 $ 3 $ 3
Interest cost 5 5 9 10
Expected return on plan assets (4) (3) (7) (6)
Net periodic benefit cost $ 3 $ 4 $ 5 $ 7
v3.25.1
Restructuring and Impairment Costs - Narrative (Details) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Nov. 30, 2022
Restructuring Cost and Reserve [Line Items]          
Aggregate amount         $ 600,000,000
Restructuring charges $ 24,000,000 $ 127,000,000 $ 33,000,000 $ 138,000,000  
Noncash and other adjustments 2,000,000 (4,000,000) (6,000,000) $ (3,000,000)  
Share Repurchase Program 2020          
Restructuring Cost and Reserve [Line Items]          
Aggregate amount 10,000,000   10,000,000    
2024 Restructuring Plan          
Restructuring Cost and Reserve [Line Items]          
Expected restructuring costs 33,000,000   33,000,000    
Expected cost remaining $ 2,000,000   $ 2,000,000    
Noncash and other adjustments   $ 2,000,000      
v3.25.1
Restructuring and Impairment Costs - Schedule of Restructuring Reserve (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Restructuring Reserve [Roll Forward]        
Restructuring reserve beginning balance $ 154 $ 54 $ 182 $ 51
2025 Plan charges 24 127 33 138
Utilized - cash (28) (8) (57) (17)
Noncash and other adjustments 2 (4) (6) (3)
Restructuring reserve ending balance 152 169 152 169
Current restructuring reserve - other current liabilities 91 64 91 64
Noncurrent restructuring reserve - other noncurrent liabilities 61 105 61 105
Employee Severance and Termination Benefits        
Restructuring Reserve [Roll Forward]        
Restructuring reserve beginning balance 165 58 181 56
2025 Plan charges 24 127 33 138
Utilized - cash (28) (8) (57) (17)
Noncash and other adjustments (6) (2) (2) (2)
Restructuring reserve ending balance 155 175 155 175
Currency Translation        
Restructuring Reserve [Roll Forward]        
Restructuring reserve beginning balance (11) (4) 1 (5)
2025 Plan charges 0 0 0 0
Utilized - cash 0 0 0 0
Noncash and other adjustments 8 (2) (4) (1)
Restructuring reserve ending balance $ (3) $ (6) $ (3) $ (6)
v3.25.1
Income Taxes (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Sep. 30, 2024
Income Tax Disclosure [Abstract]          
Income tax provision $ 48 $ 8 $ 70 $ 28  
Effective tax rate (18.00%) (20.00%) (32.00%) 117.00%  
Unrecognized tax benefits $ 418   $ 418   $ 422
Unrecognized tax benefits that would impact effective tax rate 111   111   106
Net accrued interest 20   20   $ 21
Interest and penalties accrued 1 $ 1 1 $ 3  
Uncertain tax expense position 9   9    
Audit settlement tax benefit     7    
Adjustment to net operating loss deferred tax assets 19   19    
Deferred tax liability $ 13   $ 13    
v3.25.1
Segment Information - Schedule of Financial Information for Reportable Segments (Details)
3 Months Ended 6 Months Ended
Mar. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Mar. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Mar. 31, 2025
USD ($)
segment
Mar. 31, 2024
USD ($)
Segment Reporting [Abstract]            
Number of reportable segments | segment         3  
Segment Reporting Information [Line Items]            
Net sales $ 3,611,000,000   $ 3,750,000,000   $ 7,106,000,000 $ 7,410,000,000
Adjusted EBITDA 233,000,000   227,000,000   429,000,000 443,000,000
Corporate-related costs (9,000,000)   1,000,000   (7,000,000) 2,000,000
Restructuring and impairment costs (351,000,000)   (125,000,000)   (374,000,000) (136,000,000)
Purchase accounting amortization (12,000,000)   (13,000,000)   (23,000,000) (24,000,000)
Restructuring related charges (5,000,000)   (2,000,000)   (6,000,000) 7,000,000
Gain (loss) on disposal transactions 0   0   4,000,000 (8,000,000)
Depreciation (67,000,000)   (70,000,000)   (136,000,000) (142,000,000)
Equity based compensation (5,000,000)   (10,000,000)   (10,000,000) (23,000,000)
Earnings before interest and income taxes (216,000,000)   8,000,000   (123,000,000) 119,000,000
Net financing charges (48,000,000)   (47,000,000)   (93,000,000) (91,000,000)
Other pension expense (1,000,000)   (2,000,000)   (2,000,000) (4,000,000)
Income (loss) before income taxes (265,000,000)   (41,000,000)   (218,000,000) 24,000,000
Restructuring charges 24,000,000   127,000,000   33,000,000 138,000,000
Impairment         333,000,000  
Professional fees 8,000,000          
Equity loss (18,000,000)   $ (18,000,000)   (43,000,000) (41,000,000)
Consulting fees         8,000,000  
Gain on contract settlement         2,000,000 3,000,000
Disposed of By Sale | Adient (Langfang) Seating Co., Ltd            
Segment Reporting Information [Line Items]            
Loss on disposal       $ 8,000,000   $ 8,000,000
Subsidiary, ownership percentage disposed     51.00% 51.00%   51.00%
Restatement Adjustment            
Segment Reporting Information [Line Items]            
Equity based compensation           $ (5,000,000)
Setex, Inc.            
Segment Reporting Information [Line Items]            
Gain on sale   $ 4,000,000     4,000,000  
Affilliates            
Segment Reporting Information [Line Items]            
Equity loss 1,000,000       1,000,000  
Adient Aerospace            
Segment Reporting Information [Line Items]            
Impairment of nonconsolidated partially owned affiliates         10,000,000  
Americas            
Segment Reporting Information [Line Items]            
Net sales 1,699,000,000   $ 1,660,000,000   3,310,000,000 3,307,000,000
Gain on disposition of property plant equipment         5,000,000 10,000,000
BRAZIL            
Segment Reporting Information [Line Items]            
Tax adjustments         1,000,000 1,000,000
TÜRKIYE            
Segment Reporting Information [Line Items]            
Loss on divestitures - net           2,000,000
Americas            
Segment Reporting Information [Line Items]            
Impairment         0  
EMEA            
Segment Reporting Information [Line Items]            
Restructuring charges 18,000,000       31,000,000  
Impairment         333,000,000  
Asia            
Segment Reporting Information [Line Items]            
Impairment         0  
Operating Segments            
Segment Reporting Information [Line Items]            
Adjusted EBITDA 254,000,000   249,000,000   472,000,000 488,000,000
Operating Segments | Americas            
Segment Reporting Information [Line Items]            
Net sales 1,699,000,000   1,660,000,000   3,310,000,000 3,307,000,000
Adjusted EBITDA 94,000,000   80,000,000   179,000,000 160,000,000
Operating Segments | EMEA            
Segment Reporting Information [Line Items]            
Net sales 1,231,000,000   1,370,000,000   2,360,000,000 2,638,000,000
Adjusted EBITDA 50,000,000   57,000,000   72,000,000 102,000,000
Operating Segments | Asia            
Segment Reporting Information [Line Items]            
Net sales 707,000,000   742,000,000   1,479,000,000 1,512,000,000
Adjusted EBITDA 110,000,000   112,000,000   221,000,000 226,000,000
Corporate/Eliminations            
Segment Reporting Information [Line Items]            
Net sales (26,000,000)   (22,000,000)   (43,000,000) (47,000,000)
Adjusted EBITDA (21,000,000)   (22,000,000)   (43,000,000) (45,000,000)
Corporate-related costs $ (21,000,000)   $ (22,000,000)   $ (43,000,000) $ (45,000,000)
v3.25.1
Segment Information - Schedule of Disaggregation of Revenue by Geographical Market (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Disaggregation of Revenue [Line Items]        
Net sales $ 3,611 $ 3,750 $ 7,106 $ 7,410
Americas        
Disaggregation of Revenue [Line Items]        
Net sales 1,699 1,660 3,310 3,307
United States        
Disaggregation of Revenue [Line Items]        
Net sales 1,565 1,491 3,010 2,913
Mexico        
Disaggregation of Revenue [Line Items]        
Net sales 606 628 1,214 1,260
Other Americas        
Disaggregation of Revenue [Line Items]        
Net sales 70 61 145 147
EMEA        
Disaggregation of Revenue [Line Items]        
Net sales 1,231 1,370 2,360 2,638
Germany        
Disaggregation of Revenue [Line Items]        
Net sales 242 254 451 478
Poland        
Disaggregation of Revenue [Line Items]        
Net sales 214 249 415 498
Czech Republic        
Disaggregation of Revenue [Line Items]        
Net sales 180 220 356 415
Spain        
Disaggregation of Revenue [Line Items]        
Net sales 179 206 360 386
Sweden        
Disaggregation of Revenue [Line Items]        
Net sales 142 157 281 309
Other EMEA        
Disaggregation of Revenue [Line Items]        
Net sales 579 658 1,089 1,275
Asia        
Disaggregation of Revenue [Line Items]        
Net sales 707 742 1,479 1,512
China        
Disaggregation of Revenue [Line Items]        
Net sales 286 336 621 710
Thailand        
Disaggregation of Revenue [Line Items]        
Net sales 131 126 254 248
Korea        
Disaggregation of Revenue [Line Items]        
Net sales 126 128 273 250
Japan        
Disaggregation of Revenue [Line Items]        
Net sales 106 86 213 179
Other Asia        
Disaggregation of Revenue [Line Items]        
Net sales 74 78 152 149
Inter-segment elimination        
Disaggregation of Revenue [Line Items]        
Net sales (26) (22) (43) (47)
Inter-segment elimination | Americas        
Disaggregation of Revenue [Line Items]        
Net sales (542) (520) (1,059) (1,013)
Inter-segment elimination | EMEA        
Disaggregation of Revenue [Line Items]        
Net sales (305) (374) (592) (723)
Inter-segment elimination | Asia        
Disaggregation of Revenue [Line Items]        
Net sales $ (16) $ (12) $ (34) $ (24)
v3.25.1
Nonconsolidated Partially-Owned Affiliates (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Sep. 30, 2024
Equity Method Investments and Joint Ventures [Abstract]          
Investments in partially-owned affiliates $ 293   $ 293   $ 338
Schedule of Equity Method Investments [Line Items]          
Gross profit $ 261 $ 230 477 $ 476  
Equity Method Investment, Nonconsolidated Investee or Group of Investees          
Schedule of Equity Method Investments [Line Items]          
Net sales     1,819 1,938  
Gross profit     159 204  
Net income     80 89  
Net income attributable to the entity     $ 78 $ 88  
v3.25.1
Commitments and Contingencies (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]    
Reserves for environmental liabilities $ 2 $ 3
v3.25.1
Related Party Transactions (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Sep. 30, 2024
Related Party Transaction [Line Items]          
Net sales to related parties $ 3,611 $ 3,750 $ 7,106 $ 7,410  
Purchases from related parties 3,350 3,520 6,629 6,934  
Receivables from related parties 1,887   1,887   $ 1,896
Related Party          
Related Party Transaction [Line Items]          
Net sales to related parties 28 65 84 131  
Purchases from related parties 76 $ 110 159 $ 213  
Receivables from related parties 12   12   28
Payables to related parties $ 21   $ 21   $ 114